Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,solute:sodium symporter activity (GO:0015370),0.8610836638466072,2.024350124522968,0.0,0.003088117275694184,0.003,3/27,0.63%,SLC4A10;SLC4A4;SLC5A6
prerank,glutamate receptor activity (GO:0008066),-0.7572750813989584,-2.0019370186537055,0.0,0.03473013744552464,0.033,11/19,10.73%,GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRM1;GRIK1;GRM8;GRIA2;GRIA1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.8937202316966804,1.93139549328994,0.0,0.028307741693863357,0.049,3/14,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.8191518634840518,-1.9224309798233574,0.0,0.06429768689239021,0.115,6/11,10.58%,KCNK2;KCNT2;KCND2;KCND3;KCNQ1;KCNT1
prerank,anion:anion antiporter activity (GO:0015301),0.8538327725506201,1.8784061529640899,0.0,0.07239919390794143,0.169,4/17,6.07%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.8515063007455884,1.8623652678483336,0.0,0.08080573538066449,0.227,3/15,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,chloride transmembrane transporter activity (GO:0015108),0.8452542410654877,1.846364749966894,0.00322061191626409,0.09120239687550157,0.308,3/16,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,cell adhesion mediator activity (GO:0098631),-0.6546805462480807,-1.841372775643739,0.0,0.12922114202704213,0.307,14/24,13.34%,BSG;LRRC4C;ESAM;CNTN4;CD47;SIRPA;JAM3;ROBO4;PALLD;CNTN2;NINJ1;DSCAML1;BCAM;NEXN
prerank,gap junction channel activity (GO:0005243),-0.65892999574245,-1.8294661775205907,0.005128205128205128,0.11052631578947367,0.341,5/22,4.99%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,wide pore channel activity (GO:0022829),-0.6500584951910374,-1.8002894066297543,0.005221932114882507,0.1282199128394234,0.451,5/23,4.99%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,metalloendopeptidase activity (GO:0004222),0.6572729786929709,1.7913232767112435,0.0,0.22268756799172507,0.656,13/76,6.51%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;ADAM9;ADAMTSL5;PHEX;MMP16;ADAMTS5;IDE
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8926406552877764,1.7850307244408947,0.0017211703958691911,0.20999197474720452,0.689,2/11,0.16%,SLC23A1;SLC23A2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.6148501645077378,1.7759585437730747,0.0,0.21153603338505161,0.731,15/134,3.83%,SLC26A7;SLC38A2;SLC26A2;SLC23A1;SLC23A2;SLC38A1;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1;SLC16A1;SLC6A7;ABCG2;SLC38A6;SLC26A6
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7237773422386529,-1.7674600008265904,0.007832898172323759,0.15972734383730025,0.583,4/14,4.97%,SLC7A11;SLC1A3;SLC1A1;SLC1A2
prerank,symporter activity (GO:0015293),0.9033867007465304,1.763650093082035,0.0,0.22234444384998128,0.796,2/10,0.63%,SLC4A4;SLC5A6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7628699158113855,1.7616595673990727,0.005988023952095809,0.20608035953132522,0.805,8/27,8.86%,SLC9A2;SLC23A1;SLC9B2;CNNM4;SLC9A8;SLC9C1;SLC4A8;SLC9A1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.7259361833043877,1.7531060626597932,0.005943536404160475,0.21083418854966657,0.831,3/29,3.83%,SLC26A7;SLC26A2;SLC26A6
prerank,cAMP binding (GO:0030552),-0.7496321067763899,-1.7243958364505814,0.013574660633484163,0.22313107609788801,0.741,7/11,8.32%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,solute:anion antiporter activity (GO:0140323),0.7819960138268595,1.7031140028237286,0.018121911037891267,0.363968933354734,0.959,4/14,6.07%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,nucleotidase activity (GO:0008252),0.784693038294411,1.6984473739324042,0.021035598705501618,0.3539457492911026,0.966,4/15,6.35%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7173987382167418,1.6963534797113968,0.011799410029498525,0.3367518362542706,0.967,4/31,2.62%,KCNK5;SLC12A7;SLC12A2;SLC12A8
prerank,metal ion:proton antiporter activity (GO:0051139),0.8279273103625272,1.6934376432544818,0.00819672131147541,0.3246640629179819,0.971,5/13,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,retinoid binding (GO:0005501),-0.6171824118474776,-1.6907585416163613,0.008695652173913044,0.2716225276567214,0.844,6/22,2.25%,ALDH1A2;PTGDS;NR2F2;CYP26B1;ABCA4;RBP4
prerank,cation:chloride symporter activity (GO:0015377),0.8495248225999442,1.6849782243756672,0.025996533795493933,0.3351250601893959,0.982,3/10,2.62%,SLC12A7;SLC12A2;SLC12A8
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.83047204562254,1.6849282587611247,0.011608623548922056,0.3155934753121194,0.982,5/12,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,sodium:proton antiporter activity (GO:0015385),0.8352372729473021,1.6826416929880772,0.011647254575707155,0.30600954707851075,0.984,5/11,8.86%,SLC9A2;SLC9B2;SLC9A8;SLC9C1;SLC9A1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4913129947260705,-1.670186562275207,0.0,0.29828286214474614,0.901,29/57,27.98%,COX4I1;UQCRH;UQCR10;COX5B;NDUFB9;CYB5A;COX6B1;NDUFA8;NDUFC1;COX8A;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFA4L2;NDUFS4;COX6A1;UQCR11;COX4I2;NDUFA13;COX10;NDUFB7;UQCRC1;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.7239797843880801,1.6685271308430367,0.011816838995568686,0.3364422505624716,0.991,9/27,8.08%,SLC23A1;SLC9B2;SLC12A2;CNNM2;CNNM4;ATP2B4;ITPR2;CLDN16;SLC4A8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.7072137488017061,1.6667130331901923,0.02406015037593985,0.3256934353432133,0.992,4/27,4.23%,SLC26A7;SLC26A2;SLC26A6;SLC39A14
prerank,5'-nucleotidase activity (GO:0008253),0.7963771486276456,1.665787879380756,0.021630615640599003,0.31371350102290124,0.993,4/13,6.35%,NT5E;NT5C1A;ACP3;NT5DC3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6986915485184014,-1.665138168319808,0.007792207792207792,0.2813141133087496,0.908,7/13,13.36%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5559038954431156,-1.6634013722428482,0.008928571428571428,0.2600067046597385,0.913,15/29,15.60%,GRIA4;GRID2;GABRG3;GRIK2;GABRA2;GABRB1;GRIK1;GABRB2;GABRB3;GABRA1;GRIA2;GLRA3;GABRG1;GABRA4;GABRA5
prerank,adenylate cyclase binding (GO:0008179),-0.7447337162581666,-1.659226310746412,0.016908212560386472,0.24655268745111186,0.923,6/10,13.41%,ADCY5;CAP2;CALM1;AKAP6;ADCY2;CALM3
prerank,metallopeptidase activity (GO:0008237),0.5763496263189841,1.6520968759988348,0.002355712603062426,0.3422663313894388,0.997,16/113,6.54%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;ADAMTS2;MMP28;BMP1;ADAM9;ADAMTSL5;PHEX;ADAM12;MMP16;ADAMTS5;IDE;MYSM1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6321900678380739,-1.6306045503455688,0.02972972972972973,0.2901879883442069,0.96,10/15,21.55%,COX4I1;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;COX6A1;COX4I2;COX10
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6357396691005602,1.6289282849805755,0.010610079575596816,0.4074077037774516,1.0,9/48,7.48%,PIEZO2;SLC12A7;SLC12A2;TRPM6;NALCN;TRPM4;CALHM5;TRPM7;CALHM2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6662204508504451,-1.6246016904637894,0.008152173913043478,0.282199128394234,0.963,8/15,17.02%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH1L1;ALDH4A1;ALDH9A1;ALDH1A3;ALDH3B1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.6196879273723862,1.6207401062408555,0.01804123711340206,0.42191402279171786,1.0,5/53,3.56%,SLC47A1;SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,ligand-gated channel activity (GO:0022834),-0.5493691472823449,-1.61812074474378,0.018633540372670808,0.27790367638842334,0.969,11/29,10.73%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,ligand-gated ion channel activity (GO:0015276),-0.545264115994429,-1.6156637932843287,0.012779552715654952,0.265873281930942,0.974,11/30,10.73%,GRIA4;GRID2;GRIK2;GRIN2A;GRIN2B;GABRB1;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8162341552361929,1.614965863627366,0.015570934256055362,0.4272719062650473,1.0,2/11,0.87%,EGFR;MAP3K5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7799338724365584,1.6127905793258162,0.02631578947368421,0.41895457706917766,1.0,3/13,3.11%,BMP4;BMP5;BMP6
prerank,gated channel activity (GO:0022836),0.7650416254006871,1.6081325461263072,0.031198686371100164,0.421318321156746,1.0,3/14,5.07%,PIEZO2;TMC6;TMC1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6164870262537518,1.6013104743142914,0.01935483870967742,0.4325202351016914,1.0,7/55,3.56%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6
prerank,chemoattractant activity (GO:0042056),0.6822435148553215,1.5975142301247443,0.03259259259259259,0.4316265065797848,1.0,7/26,10.91%,BMP4;PGF;FGF2;DEFB130A;GDNF;VEGFA;CCL3
prerank,anion channel activity (GO:0005253),0.5991507514499049,1.5935340530179354,0.011583011583011582,0.4324736682538833,1.0,7/61,4.00%,SLC26A7;CLIC4;LRRC8D;ANO6;GLRB;ANO9;GABRA3
prerank,mechanosensitive ion channel activity (GO:0008381),0.7696785553281715,1.5826658503980509,0.045454545454545456,0.4591333072153063,1.0,3/12,5.07%,PIEZO2;TMC6;TMC1
prerank,potassium ion antiporter activity (GO:0022821),0.7404034432150657,1.5733897489287616,0.05263157894736842,0.47997706115242633,1.0,5/15,8.86%,SLC9A2;SLC24A3;SLC9A8;SLC9C1;SLC9A1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.584126332540273,-1.573142576586601,0.03389830508474576,0.3529332886356017,0.996,7/18,17.02%,ALDH1A2;ALDH1A1;FAR2;ALDH9A1;HSD17B12;ALDH1A3;ALDH3B1
prerank,BMP receptor binding (GO:0070700),0.7799358153015875,1.5730799053297764,0.03541315345699832,0.46652406035638605,1.0,3/12,3.11%,BMP4;BMP5;BMP6
prerank,endopeptidase activity (GO:0004175),0.5172591085726969,1.5645521701257996,0.0010395010395010396,0.48283621875265537,1.0,48/257,14.27%,ADAMTSL3;F3;ADAMTS17;ADAMTSL1;THSD4;TRABD2B;HTRA3;PCSK5;ADAMTS2;MMP28;ADAM9;USP46;USP2;USP13;ADAMTSL5;USP24;DDI2;PRSS12;CASP6;PHEX;HTRA4;MMP16;TASP1;ADAMTS5;IDE;PSMB2;PGC;ASPRV1;NLN;USP34;USP49;BACE2;MMP14;USP15;USP25;USP1;USP10;USP7;USP47;ADAMTS3;USP33;PMPCB;CLPP;OMA1;PITRM1;PREP;ECE1;PCSK7
prerank,potassium:proton antiporter activity (GO:0015386),0.7914071056058797,1.56443438994186,0.050761421319796954,0.4693055939833533,1.0,4/10,8.86%,SLC9A2;SLC9A8;SLC9C1;SLC9A1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6243431485453672,-1.555214409573973,0.0395778364116095,0.3807278280627258,0.997,4/15,4.97%,SLC1A3;SLC1A1;SLC1A5;SLC1A2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5981407663459647,1.5544219805949522,0.03557312252964427,0.49341251582758183,1.0,5/51,1.49%,SLC4A4;SLCO3A1;SLC5A6;SLCO2A1;SLCO4A1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.7552797180727687,1.5528811908112918,0.05555555555555555,0.4855855759456423,1.0,3/12,10.94%,AOX1;FDX1;CISD2
prerank,I-SMAD binding (GO:0070411),0.7373460702587256,1.5525755474771183,0.06026058631921824,0.47397182432299245,1.0,6/13,13.35%,SMAD9;SMAD6;TGFBR1;TGFB1I1;SMAD2;SMURF1
prerank,leucine zipper domain binding (GO:0043522),0.781067142520609,1.547605550835582,0.05136986301369863,0.47913327269809,1.0,5/10,12.04%,PAWR;ERC1;MRTFA;DDIT3;AATF
prerank,insulin-like growth factor I binding (GO:0031994),-0.6292457670486566,-1.5439341674745333,0.04156479217603912,0.3911216189988885,1.0,6/13,3.90%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6106869673286524,1.5398126031768609,0.03137789904502047,0.49453624739179286,1.0,3/47,0.29%,SLC47A1;SLC38A2;SLC38A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6432076809006918,-1.5359978213639143,0.04100227790432802,0.3927321488434462,1.0,8/12,12.34%,PDE8B;PDE4B;PDE7B;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7123610964053873,1.533452212179632,0.04700162074554295,0.5062001667686679,1.0,6/18,6.45%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,R-SMAD binding (GO:0070412),0.698297853373009,1.529253191781408,0.06191950464396285,0.5102501076402954,1.0,9/18,13.40%,DDX5;SMAD6;PMEPA1;LDLRAD4;JUN;SMAD2;PPM1A;SMURF1;PAX6
prerank,chloride channel activity (GO:0005254),0.5819032103047366,1.5276481144470797,0.030065359477124184,0.503985527172013,1.0,7/59,5.97%,SLC26A7;CLIC4;ANO6;GLRB;ANO9;GABRA3;CLIC1
prerank,calcium activated cation channel activity (GO:0005227),0.702149219292851,1.5265249480146492,0.06800618238021638,0.496672195174148,1.0,4/17,4.96%,KCNMB3;KCNMB2;ANO6;TRPM4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.7347320252686785,1.519428968262535,0.07543859649122807,0.5101340990018963,1.0,5/14,11.54%,CAPN5;CAPN2;CAPN6;CAPN10;CAPN12
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6702740903869348,-1.5191157051718274,0.07077625570776255,0.42141021343166835,1.0,3/10,2.89%,SLC6A13;SLC6A12;SLC6A1
prerank,calcium-activated potassium channel activity (GO:0015269),0.7542224295030387,1.5182066326864636,0.06168831168831169,0.5034078712609882,1.0,2/11,0.90%,KCNMB3;KCNMB2
prerank,retinoic acid binding (GO:0001972),-0.642153662225214,-1.5180738166789074,0.06683168316831684,0.4052844909029958,1.0,2/12,1.99%,NR2F2;CYP26B1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6553202621627532,-1.5154840902184057,0.06265060240963856,0.39415237068023146,1.0,2/11,4.69%,ITPR1;RYR2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6802966523480766,-1.5120930963066803,0.05238095238095238,0.3862163370208962,1.0,4/10,6.79%,PRKAR2B;PRKAG2;PRKAR1B;PRKAR1A
prerank,MHC class I protein binding (GO:0042288),-0.6119905782122197,-1.4933110631527071,0.059665871121718374,0.4199155212872947,1.0,6/13,22.00%,ATP5F1B;TAP2;ATP5F1A;ABCB9;TUBB4B;TAPBP
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.5819606609607996,-1.4922016224664227,0.056265984654731455,0.40665308543283735,1.0,9/16,27.92%,SLC44A1;SLC22A4;SLC22A2;SLC44A2;SLC22A3;SLC5A7;SLC29A4;SLC7A8;SLC25A42
prerank,GABA-A receptor activity (GO:0004890),-0.5739249196812083,-1.4918051206810157,0.06925207756232687,0.3924609826051328,1.0,9/18,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6264300368664822,1.4873179346986114,0.06896551724137931,0.6071107154768992,1.0,6/32,7.03%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SFXN3;SLC6A19
prerank,delayed rectifier potassium channel activity (GO:0005251),0.6129901613260238,1.4793724671329815,0.057971014492753624,0.6246146095268668,1.0,4/32,3.00%,KCNB2;KCNQ5;KCNS3;KCNB1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.7147253586827211,1.4777505618111806,0.07281553398058252,0.6183587211568592,1.0,8/14,18.54%,USP13;MINDY3;USP15;DESI2;USP7;OTUD7B;OTUD5;USP9X
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6471124549447642,-1.4769498261207585,0.0611764705882353,0.4151190077103587,1.0,6/11,13.73%,ITPR1;TRPC3;TRPC4;TRPC6;RPH3A;TRPC1
prerank,ATPase binding (GO:0051117),0.5452901868867787,1.473948790987105,0.0422360248447205,0.6197439623348134,1.0,12/71,7.42%,EGFR;SLC2A13;PTPN3;ANK2;ATP1B1;PPP3CA;EZR;ATP6V0A4;SNTA1;ESR1;TOR1AIP1;RDX
prerank,SUMO transferase activity (GO:0019789),0.6808419258676198,1.4709095737267535,0.09181969949916527,0.618915216613637,1.0,5/16,9.73%,HDAC4;PIAS2;PIAS3;EGR2;RANBP2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6141824585508465,-1.4675520525079726,0.0810126582278481,0.42394719502468003,1.0,9/12,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GABRA1;GABRG1;GABRA4;GABRA5
prerank,receptor antagonist activity (GO:0048019),0.6776612571001502,1.4671190958465623,0.09193548387096774,0.6209095286501525,1.0,6/17,10.12%,ADH7;ESR2;LRPAP1;IGSF1;DKK3;IL18BP
prerank,histone acetyltransferase activity (GO:0004402),0.6201618661309649,1.4621485351404186,0.06637806637806638,0.6290630845437669,1.0,22/30,28.11%,KAT6B;NAA40;CREBBP;TADA3;SRCAP;BRCA2;KAT2A;BAZ1A;EP300;ATF2;EPC1;KAT2B;USP22;KAT5;NAA50;HAT1;TAF1;KAT14;KAT6A;NAA60;TAF9;TADA2A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6371369160367989,-1.4610832984677025,0.05502392344497608,0.4264610571013521,1.0,6/11,31.96%,PPP1R1A;PPP1R14A;PABIR1;PPP1R2;PPP1R8;PPP1R11
prerank,insulin-like growth factor binding (GO:0005520),-0.5722141224048396,-1.4490632107727257,0.06467661691542288,0.4423777751343636,1.0,6/15,3.90%,IGF1R;IGFBP2;ITGA6;IGFBP3;IGFBP4;INSR
prerank,phospholipase inhibitor activity (GO:0004859),0.7318673318482029,1.4475181857119048,0.1245674740484429,0.6726758174363973,1.0,3/10,2.53%,ANXA1;ANXA2;ANXA4
prerank,histone deacetylase activity (GO:0004407),0.6641736467206619,1.443900208197071,0.07987220447284345,0.6748004143948716,1.0,6/19,17.31%,HDAC4;HDAC9;HDAC8;MIER1;HDAC10;SIRT6
prerank,monocarboxylic acid binding (GO:0033293),-0.5440897330515704,-1.4367051944478288,0.05994550408719346,0.46035031847133756,1.0,5/18,15.34%,NR2F2;CYP26B1;NAPEPLD;NR1H4;PSAP
prerank,manganese ion binding (GO:0030145),0.5583545314975298,1.4361740740082936,0.06430446194225722,0.6946609521771363,1.0,11/48,13.91%,ME1;MPPED2;LARGE1;ABL1;XPNPEP1;B4GALT1;XPNPEP3;WRN;DYRK2;LARGE2;MGAT1
prerank,cholesterol transfer activity (GO:0120020),-0.557228353965214,-1.4350028597457325,0.10864197530864197,0.450780686516523,1.0,5/16,9.42%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,calcium channel regulator activity (GO:0005246),-0.45203561764530875,-1.4326423975990834,0.05405405405405406,0.44279544871921284,1.0,9/37,9.55%,ITPR1;PRKG1;NRXN1;CALM1;SGK1;REM1;CACNG4;CACNG7;SLC30A1
prerank,cation transmembrane transporter activity (GO:0008324),0.5643543982424283,1.4297936244275609,0.08,0.7079373410788755,1.0,6/48,6.91%,SLC38A2;SLC38A1;SLC6A7;SLC38A6;SFXN3;SLC7A2
prerank,mRNA methyltransferase activity (GO:0008174),0.7044068813624793,1.4262407995831083,0.12307692307692308,0.7103557124118375,1.0,1/12,0.75%,RNMT
prerank,phosphatase binding (GO:0019902),0.5007221758051583,1.424085301602039,0.04463208685162847,0.7065856584651908,1.0,25/105,11.40%,EGFR;MET;MAP3K5;WNK1;PPP1R3C;CRY2;SHOC2;ANAPC5;SFI1;VCP;AP3B1;STAT3;DLG1;FCRL6;VRK3;JUP;IKBKE;STYXL1;CNST;CDKN1B;IQGAP1;PPP6R3;SMAD2;ERBB2;MAST2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.45529621367198914,1.4205968556389517,0.0,0.7082253847662868,1.0,145/597,17.23%,BNC2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;PRRX2;RARB;NFIB;SOX9;ZIC4;HDAC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;SMAD6;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;NFE2L2;ZIC1;ELF1;CRY2;ABL1;NR2F1;FOXC2;JDP2;HOXA6;GLIS1;NR4A2;FOXK1;ARID4A;KLF10;ZBTB7B;NFATC4;BHLHE40;ARID4B;GLIS2;ISL1;ESR1;STAT3;GATA4;DDIT3;HOXB5;TBL1X;E2F3;HOXC4;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;IRF1;NFIX;SIX4;TEAD1;GABPB1;GABPB2;PITX2;MCM7;RXRA;FOXC1;NFYA;GLI2;PER3;EGR2;NFKB1;GATA1;CTCFL;MCM2;RARG;HOXB4;ATF7;RARA;JUN;LBX1;ELF3;FOXE1;NCOR1;ZBTB32;PER1;ATF6;DDX11;ZBED4;NFKB2;FOXK2;ATOH7;NKX2-1;BCL11B;NR4A1;CDC45;NR6A1;KMT2D;NFATC3;HNF1A;HNF4A;RFX2;XRCC5;PAX6;CHD3;MLH3;SP3;E2F2;NFATC1;REST;ETV3;DHX9;FOXD2;CREB3L1;ATF2;RFX7;MCM9;HOXD3;HINFP;TFAP2A;ZBTB7A;HSF2;BCL6;ZFP1;CALCOCO1;POU6F1;XPA;PRDM5;YY1;ZNF76;ZBTB37;CREB3L3;POU3F4;HOXA2;SREBF1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.6054904541309247,-1.4156544693974036,0.09181141439205956,0.47367080120683874,1.0,9/12,35.60%,SLC2A1;SLC5A3;MFSD4A;SLC2A4;SLC2A8;PPBP;SLC2A5;SLC2A3;SLC2A6
prerank,sequence-specific DNA binding (GO:0043565),0.45512817927992666,1.4150711848820987,0.0,0.7189575766718618,1.0,92/590,10.53%,FOXP2;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;TCF7L2;SLTM;PRRX2;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;JDP2;HOXA6;GLIS1;FOXL1;NR4A2;SMG6;TELO2;FOXK1;KLF10;ZBTB7B;NFATC4;BHLHE40;GLIS2;ISL1;ESR1;KDM1A;MBD1;GATA4;HOXB5;E2F3;HOXC4;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;NFIX;SIX4;TEAD1;PITX2;STN1;RXRA;GRHL2;FOXC1;RORA;GLI2;EGR2;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;JUN;LBX1;ELF3;FOXE1
prerank,double-stranded DNA binding (GO:0003690),0.45552644271651094,1.414249932046841,0.0010090817356205853,0.7107816596222781,1.0,120/531,17.23%,EGFR;FOXP1;KLF12;VSX1;NR3C2;TBX15;TCF7L1;KLF5;TFCP2L1;SIX1;PRRX2;RARB;NFIB;SOX9;ZIC4;HOXA5;PBX1;KLF3;CUX1;NFAT5;GLI3;FOXO3;MEOX2;HES1;GRHL1;HOXB6;KLF4;ZIC1;ELF1;ABL1;NR2F1;FOXC2;JDP2;HOXA6;GLIS1;NR4A2;FOXK1;HDGFL3;KLF10;ZBTB7B;NFATC4;BHLHE40;GLIS2;ISL1;ESR1;MBD1;GATA4;HOXB5;E2F3;HOXC4;DMRT3;MYOG;DMBX1;PITX3;BARHL2;PHOX2A;SOX14;SP8;MBNL2;NFIX;SIX4;TEAD1;PITX2;ERCC5;CAMTA2;RXRA;GLI2;EGR2;GATA1;RARG;HOXB4;ATF7;RARA;TOP1;JUN;LBX1;APEX1;ELF3;FOXE1;ZBTB32;SMAD2;ATF6;DDX11;NFKB2;ATOH7;BCL11B;NR4A1;NR6A1;NFATC3;HNF4A;PRKDC;RFX2;XRCC5;PAX6;SP3;E2F2;NFATC1;POLG2;ETV3;DHX9;FOXD2;CREB3L1;ATF2;RFX7;HOXD3;KIN;TFAP2A;ZBTB7A;HSF2;BCL6;ZFP1;RBBP8;POU6F1;XPA;YY1;ZNF76;ZBTB37;POU3F4;HOXA2;SREBF1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.718192801398123,1.4125330630953543,0.10471204188481675,0.7064599293607907,1.0,5/10,19.11%,DSE;GLCE;RENBP;GALE;GNE
prerank,sterol transfer activity (GO:0120015),-0.5433280255880087,-1.411286401412176,0.10864197530864197,0.4716206652512385,1.0,5/17,9.42%,PLTP;GRAMD1B;ABCA1;ABCG1;NPC2
prerank,Notch binding (GO:0005112),0.6285323890630315,1.4089767473978203,0.09701492537313433,0.7095914477556042,1.0,8/22,13.95%,CCN3;SNED1;TCIM;JAG1;AAK1;GALNT11;NCOR2;CUL3
prerank,transcription corepressor binding (GO:0001222),0.5917449308612045,1.404587350207221,0.11213517665130568,0.7156988925151142,1.0,13/27,18.96%,ZBTB16;ESR1;LCOR;EHMT1;RORA;PER3;PER1;EED;SUZ12;ZBTB7A;EHMT2;PER2;NEK6
prerank,mannose binding (GO:0005537),0.6914423046648173,1.4039879126572654,0.13541666666666666,0.707241242341558,1.0,2/12,5.88%,COLEC11;LMAN2L
prerank,cation channel activity (GO:0005261),0.5105528823455946,1.4037246491730118,0.05507955936352509,0.697760866631478,1.0,12/94,5.98%,PIEZO2;KCNK5;SLC24A3;PKD1;ANXA2;ANO6;TRPM6;NALCN;TRPM4;PKD2L2;CALHM5;TRPM7
prerank,thiol-dependent deubiquitinase (GO:0004843),0.5116651170041999,1.40296748834783,0.06862745098039216,0.6904061407346096,1.0,37/83,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,GTPase regulator activity (GO:0030695),-0.3421743172123678,-1.4020185223373602,0.0,0.4836342879923168,1.0,57/212,11.05%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;CHN2;ERRFI1;ARHGAP24;RASGRP3;ARHGAP32;ALDH1A1;RGS3;RAPGEF2;CPEB2;RGS5;RGS7;RIMS1;RALGAPA2;USP6NL;ARHGAP26;RABGAP1L;ARAP3;RGS12;RALGAPA1;CHN1;IQGAP2;TNK2;SIRPA;TBC1D12;ARHGAP25;CCDC88A;OPHN1;VAV3;TBC1D8;ADGRB3;TBC1D9;RHOH;ARL2BP;ARHGAP39;GMIP;ARHGAP15;ACAP2;ABR;HACD3;GARNL3;TBC1D1;SYDE2;TBC1D16;TBC1D30;SMAP2;RGS16;SIPA1;ELMOD1;RP2;RGS20
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5704290663129616,1.4017512902783908,0.0988538681948424,0.6851144819757474,1.0,14/33,16.96%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;ERBB2;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6984698520553706,1.3990764499123218,0.11925042589437819,0.6849297064286096,1.0,6/11,22.08%,UBE4B;UBR5;UBE4A;UBE2K;PPIL2;ANAPC11
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5460390072412432,-1.3942492399402453,0.09893048128342247,0.4909645888102758,1.0,4/17,11.33%,SLC2A1;SLC5A3;SLC5A11;MFSD4A
prerank,cyclic nucleotide binding (GO:0030551),-0.5163481058110899,-1.390204543515607,0.0859375,0.4893748334579712,1.0,7/21,8.32%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4D;PDE2A;PDE4A
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5407679184851265,1.390013555730663,0.0885558583106267,0.7091216153590528,1.0,7/46,6.14%,EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;MGAT3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7070720396876267,1.3888040440279414,0.13541666666666666,0.7039906609835987,1.0,3/10,5.69%,EHHADH;AUH;ECHDC1
prerank,androgen receptor binding (GO:0050681),0.6080221571605634,1.3882917854704628,0.11544461778471139,0.696321092196596,1.0,11/25,20.23%,FOXP1;DDX5;KDM1A;TGFB1I1;SMARCA4;EP300;ZBTB7A;NSD1;RNF14;SNW1;TMF1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.44475913589357563,1.388034953320015,0.001002004008016032,0.6877877053127173,1.0,130/732,11.53%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;FOXN3;PBX1;KLF3;FOXP4;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;SKIL;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;ISL1;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;NFKB2;BPTF;FOXK2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4607682795740583,1.3812664316915282,0.03399122807017544,0.7028829418793358,1.0,46/188,13.50%,BNC2;VSX1;SIX1;TCF7L2;HDAC4;PBX1;SMAD6;FOXO3;GRHL1;KLF4;NFE2L2;CRY2;FOXC2;FOXK1;ARID4A;ARID4B;GLIS2;STAT3;GATA4;DDIT3;TBL1X;IRF1;GABPB1;GABPB2;PITX2;RXRA;FOXC1;NFYA;PER3;EGR2;NFKB1;GATA1;CTCFL;JUN;NCOR1;PER1;ATF6;ZBED4;FOXK2;NKX2-1;KMT2D;HNF1A;HNF4A;XRCC5;PAX6;CHD3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6909660379734619,1.3801062420898789,0.13366336633663367,0.6979551374289342,1.0,5/12,9.27%,DDI2;SPPL2A;PGC;ASPRV1;BACE2
prerank,cholesterol binding (GO:0015485),-0.4316109521486204,-1.3784613390519926,0.08582089552238806,0.5080690579953068,1.0,14/47,10.47%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;ABCG1;CD81;NPC2;OSBPL1A;SYP
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.44095024169351094,1.376454840849527,0.002004008016032064,0.701216517151459,1.0,181/731,17.23%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;FOXP4;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;SKIL;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;NOBOX;PITX3;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;NFKB2;BPTF;FOXK2;MTA1;ATOH7;NKX2-1;BCL11B;NR4A1;NR6A1;NFATC3;MXD4;TCF3;HNF1A;HNF4A;RFX2;PAX6;CC2D1B;SP3;E2F2;EBF4;NFATC1;REST;ZNF691;DHX9;FOXD2;DNMT3A;STAT5A;CREB3L1;ATF2;RFX7;ZBTB1;HOXD3;TWIST1;ZNF585B;ZNF585A;HINFP;TFAP2A;THRAP3;ZNF219;ZBTB7A;HSF2;BCL6;ZFP1;CALCOCO1;POU6F1;PRDM5;NSD1;YY1;ZNF76;ZBTB37;ZKSCAN1;POU6F2;CREB3L3;POU3F4;HOXA2;SREBF1
prerank,serine-type peptidase activity (GO:0008236),0.4896499575222055,1.3743105882856081,0.0671462829736211,0.7006199061937117,1.0,5/96,4.72%,F3;HTRA3;PCSK5;HTRA1;PRSS12
prerank,cytokine activity (GO:0005125),0.4781881061749624,1.3735044132910639,0.046189376443418015,0.6947742669083949,1.0,25/131,11.38%,BMP4;TNFRSF11B;WNT9A;BMP5;TGFB3;WNT11;BMP6;INHBA;FGF2;FAM3C;CLCF1;WNT16;SLURP1;GDF6;IL10;GDF5;CXCL2;GDF10;CTF1;IL33;VEGFA;CCL3;TIMP1;CCL1;INHBB
prerank,acetylation-dependent protein binding (GO:0140033),0.6095367947776367,1.3686619926694397,0.13479623824451412,0.6941909719538881,1.0,7/20,17.73%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.6095367947776367,1.3686619926694397,0.13479623824451412,0.6941909719538881,1.0,7/20,17.73%,MLLT3;BRD3;ZMYND8;BRD9;SMARCA4;BAZ2A;CARM1
prerank,transforming growth factor beta binding (GO:0050431),0.6014198658921643,1.3672138706285892,0.1402439024390244,0.690846983875114,1.0,9/23,6.98%,THBS1;CD109;TGFB3;TGFBR1;LTBP3;TGFBR2;TSKU;ITGAV;LTBP4
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5501862274181955,-1.3667330688170247,0.11528822055137844,0.5286215383105892,1.0,6/14,5.98%,COL4A3;TIMP3;SPOCK2;SPOCK3;SPOCK1;BST2
prerank,GABA receptor binding (GO:0050811),-0.5988350523792189,-1.3655365668449437,0.12832929782082325,0.5193876410772152,1.0,6/11,25.35%,PLCL2;JAKMIP1;GABARAPL1;GABARAP;TRAK2;GABARAPL2
prerank,potassium channel activity (GO:0005267),0.49049912337446655,1.365411865366519,0.07551766138855055,0.6885757400153285,1.0,7/89,3.00%,KCNB2;KCNK5;KCNMB3;KCNMB2;KCNQ5;KCNS3;KCNB1
prerank,aspartic-type peptidase activity (GO:0070001),0.6939787068898863,1.365244685240797,0.15630252100840336,0.6809053504233002,1.0,4/10,9.27%,DDI2;PGC;ASPRV1;BACE2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.48526487742076546,-1.361720288805179,0.10031347962382445,0.5167172114852381,1.0,11/24,24.45%,RPS14;RPS13;RPL41;RPS7;RPL26;MYH10;MRPS11;DDX3X;RPL5;IGF2BP1;SHMT2
prerank,deubiquitinase activity (GO:0101005),0.49543758096390034,1.3613750234618764,0.07985257985257985,0.6856710275785451,1.0,37/88,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,sterol binding (GO:0032934),-0.4056295990599571,-1.3607028397754015,0.08627450980392157,0.5077042635540792,1.0,15/56,10.47%,OSBPL8;APOD;SIDT1;PROM1;OSBPL10;PTCH1;GRAMD1B;NR1H3;ABCA1;INSIG2;ABCG1;CD81;NPC2;OSBPL1A;SYP
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.5951757663880891,-1.3595448475086218,0.10073710073710074,0.4993630573248408,1.0,4/11,10.72%,KCNJ3;KCND3;KCNQ1;KCNJ8
prerank,amino acid:sodium symporter activity (GO:0005283),0.6660659591996739,1.3588854412968892,0.17353951890034364,0.6857296074593792,1.0,2/11,0.29%,SLC38A2;SLC38A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5730750808041987,-1.351779459006378,0.14460784313725492,0.5078925505400166,1.0,3/12,4.13%,CDK8;CDK19;CDK6
prerank,histone methyltransferase activity (GO:0042054),0.5614141751414046,1.3479755972344594,0.1258741258741259,0.7148222421879852,1.0,13/32,22.25%,SMYD2;KMT2C;SETD2;EHMT1;PRMT8;EED;PRMT6;SUZ12;KMT5A;CARM1;EHMT2;KMT5B;PRMT5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5872223527746678,-1.3472574174928043,0.1391509433962264,0.5089093515738119,1.0,3/11,5.71%,SASH1;ROR2;DAB2IP
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5161114299732039,-1.34437573268059,0.11232876712328767,0.4953211053110483,1.0,4/16,4.40%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5161114299732039,-1.34437573268059,0.11232876712328767,0.4953211053110483,1.0,4/16,4.40%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,copper ion binding (GO:0005507),-0.41795200373003044,-1.343795865252691,0.07092198581560284,0.48669125041904127,1.0,7/42,8.56%,PAM;MOXD1;LOXL3;SOD3;SNCA;ATOX1;LACC1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6797558397183406,1.3418525859841004,0.18181818181818182,0.7282108063676732,1.0,3/10,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,RNA polymerase II complex binding (GO:0000993),0.5517331069152323,1.3383343679476978,0.1355206847360913,0.7322539057733127,1.0,13/32,16.96%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,H4 histone acetyltransferase activity (GO:0010485),0.69801837642122,1.3361307715376651,0.15699658703071673,0.7315406701977778,1.0,8/10,27.51%,NAA40;BRCA2;EP300;ATF2;USP22;NAA50;HAT1;NAA60
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.43855588798502704,-1.3357767127777564,0.08361204013377926,0.487413290698574,1.0,16/34,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.43855588798502704,-1.3357767127777564,0.08361204013377926,0.487413290698574,1.0,16/34,27.98%,NDUFB9;NDUFA8;NDUFC1;NDUFB8;NDUFB3;NDUFA4;NDUFA1;NDUFA3;NDUFS4;NDUFA13;NDUFB7;NDUFA2;NDUFA6;NDUFA10;NDUFS6;NDUFV3
prerank,microtubule plus-end binding (GO:0051010),0.612250235000502,1.3347941424831893,0.16057233704292528,0.7282074642494094,1.0,5/20,9.47%,CLIP4;MAPRE2;CLIP1;PAFAH1B1;FBXW11
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4883768005273315,1.3327531771097436,0.10349127182044887,0.7272851849181076,1.0,14/70,13.84%,EXT1;MGAT4C;B3GNT2;GXYLT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;B3GALT6;B4GAT1;B4GALNT3;LARGE2
prerank,ligand-gated anion channel activity (GO:0099095),-0.51784452231655,-1.3318670159615862,0.13387978142076504,0.48664697436416426,1.0,11/17,15.60%,GABRG3;GABRA2;GABRB1;GABRB2;GABRB3;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5254658362356254,-1.3314324903591603,0.13972602739726028,0.4788517649395961,1.0,3/16,4.69%,SLC13A3;SLC1A1;SLC1A5
prerank,omega peptidase activity (GO:0008242),0.481046411619646,1.330719258549841,0.11231884057971014,0.7263495339888152,1.0,37/89,20.81%,TANK;USP46;USP2;USP13;OTUD1;MINDY3;USP24;MYSM1;USP34;USP49;USP15;USP25;USP1;USP10;USP32;DESI2;USP7;OTUD7B;USP47;COPS5;USP4;USP33;ZC3H12A;ZRANB1;JOSD1;BAP1;OTUD3;OTUD5;VCPIP1;USP28;USP22;USP9X;UFD1;USP40;PSMD14;USP21;USP36
prerank,ligand-gated calcium channel activity (GO:0099604),-0.49847965292525503,-1.3281887237609609,0.14804469273743018,0.4781495139121689,1.0,5/19,7.94%,ITPR1;GRIN2A;RYR2;GRIN2B;GRIN1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5235253643952498,1.3268407961520743,0.13165266106442577,0.732080908208183,1.0,12/42,13.02%,PTPN3;NEDD4;VAV2;SHC1;ABL1;IRS1;NCK2;CBLC;BCAR3;PLCG2;PIK3R3;YES1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42276803487212944,1.32394065164885,0.002002002002002002,0.7338558551962807,1.0,137/831,11.53%,FOXP2;ZBTB7C;FOXP1;KLF12;NR3C2;PBX3;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;SIX1;TCF7L2;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;KLF3;FOXP4;CUX1;NFIA;NFAT5;GLI3;FOXO3;MEOX2;HOXA3;ZBTB16;HES1;GRHL1;TWIST2;SKIL;PURG;HOXB6;ESR2;KLF4;NFE2L2;ZNF148;ZIC1;ELF1;PRRX1;ZNF423;NR2F1;FOXC2;MEF2A;KLF7;JDP2;HOXA6;GLIS1;EHF;NR4A3;FOXL1;NR4A2;FOXK1;KLF10;ZBTB7B;HOXC6;FOXO6;NFATC4;BHLHE40;KLF9;GLIS2;SKI;ESR1;STAT3;ATF1;HOXB3;E2F5;GATA4;DDIT3;HOXB5;NFIL3;HIF3A;E2F3;HOXC4;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;PHOX2A;LHX2;SOX14;SP8;IRF1;NFIX;REL;SIX4;TEAD1;PITX2;MLXIP;HIVEP3;RXRA;ZNF8;GRHL2;ATOH8;FOXC1;NFYA;RORA;GLI2;EGR2;NFKB1;GATA1;CTCFL;RARG;HOXB4;ATF7;RARA;RBMX;TOP1;JUN;NFE2L1;NRF1;CARF;FOXE1;ZNF25;PRDM15;ZBTB32;MYNN;PER1;SMAD2;ATF6;MXD1;GTF2IRD1;RB1;NFKB2;BPTF;FOXK2
prerank,lipid phosphatase activity (GO:0042577),0.6331135292272543,1.3234243985231369,0.17857142857142858,0.7278628083034614,1.0,2/14,2.22%,PLPPR2;PLPP3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4374575416485812,1.3204419838927377,0.05813953488372093,0.7305891197428388,1.0,67/254,15.71%,KLF5;TFCP2L1;SIX1;PLAGL1;NFIB;SOX9;HOXA5;NFIA;NFAT5;FOXO3;MEOX2;ZBTB16;GRHL1;KLF4;ELF1;PRRX1;FOXC2;MEF2A;KLF7;EHF;NR4A3;NR4A2;KLF10;GLIS2;ESR1;STAT3;ATF1;HOXB3;GATA4;DDIT3;E2F3;PLSCR1;HOXC4;MYOG;IRF1;REL;MLXIP;MDM4;GRHL2;FOXC1;EGR2;NFKB1;GATA1;CTCFL;JUN;NRF1;ELF3;PRDM15;SMAD2;ATF6;NFKB2;FOXK2;NR4A1;NFATC3;TCF3;HNF1A;HNF4A;E2F2;NFATC1;FOXD2;CREB3L1;ATF2;HOXD3;ZNF585B;ZNF585A;HINFP;TFAP2A
prerank,death receptor binding (GO:0005123),0.6269682429115642,1.3201353473021105,0.1702127659574468,0.7241109821489989,1.0,5/15,15.32%,NGF;EDA;FEM1B;MYD88;PIDD1
prerank,ephrin receptor activity (GO:0005003),-0.5161518528022907,-1.3182271252189453,0.18328840970350405,0.4842128788279784,1.0,8/17,14.30%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5161518528022907,-1.3182271252189453,0.18328840970350405,0.4842128788279784,1.0,8/17,14.30%,EPHA7;EPHB1;EPHA4;EPHB4;EPHA8;EPHA6;EFNB3;EPHA5
prerank,sodium channel activity (GO:0005272),-0.42731728000662095,-1.3169341526903873,0.10423452768729642,0.4787450726530801,1.0,11/37,16.15%,SCN7A;SHROOM2;GRIK2;HCN1;GRIK1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,GTPase inhibitor activity (GO:0005095),0.645648078483701,1.3143858936887176,0.18016528925619835,0.7367707139340545,1.0,2/13,4.13%,SLIT2;PDE6D
prerank,protein kinase C binding (GO:0005080),0.5227062343990638,1.313929508432647,0.15172413793103448,0.7309779466053181,1.0,12/43,12.68%,GRK5;ADAM9;HDAC9;DSP;ABL1;IRS1;NELL1;ITGAV;PDLIM5;DACT1;PRKCSH;CAVIN2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6286214527851137,1.3074969618020813,0.19736842105263158,0.745693691727527,1.0,1/14,0.28%,KCNJ2
prerank,phospholipid transfer activity (GO:0120014),0.5814449563897385,1.3061190407793937,0.16377952755905512,0.7429243181944545,1.0,3/21,2.58%,TNFAIP8L3;PITPNC1;PITPNA
prerank,glucuronosyltransferase activity (GO:0015020),0.5891752558413913,1.3008301046207709,0.17673716012084592,0.7542801400185852,1.0,4/19,13.84%,EXT1;LARGE1;B4GAT1;LARGE2
prerank,protein phosphatase binding (GO:0019903),0.45557652263173,1.2988887804590346,0.11216056670602124,0.7534412283986944,1.0,24/117,11.10%,EGFR;MET;MAP3K5;PPP1R3B;PPP1R3C;STRN;SHOC2;ANAPC5;VCP;AP3B1;ATP2B4;STAT3;FCRL6;VRK3;JUP;IKBKE;STYXL1;STRN3;CDKN1B;SLC9A1;IQGAP1;BOD1L1;PPP6R3;ERBB2
prerank,poly-purine tract binding (GO:0070717),-0.4506818334038556,-1.2987876629840849,0.13975155279503104,0.5129655619129871,1.0,5/27,6.82%,RBPMS;RBMS1;ATXN1;KHDRBS2;ELAVL4
prerank,GTPase activator activity (GO:0005096),-0.3078355890502813,-1.2946735732928276,0.0,0.5140060341937647,1.0,81/313,11.92%,RANBP3L;PLCB1;ASAP1;PREX2;ARHGAP28;ARHGAP29;TBC1D4;RAPGEF5;DOCK10;CHN2;RAPGEF4;ERRFI1;ARHGAP24;DENND2A;RASGRP3;ELMO1;ARHGAP32;DOCK11;RAPGEF3;ALDH1A1;RGS3;FGD5;DOCK4;SBF2;RAPGEF2;RGS5;RALGPS1;RGS7;RALGAPA2;USP6NL;ARHGAP26;RABGAP1L;RASGRF2;ARAP3;RASGRP2;RASGRF1;RALGAPA1;CHN1;IQGAP2;ARHGEF15;EEF1B2;EPS8L2;RGL1;RAB3IP;TBC1D12;ARHGAP25;CCDC88A;OPHN1;VAV3;DENND5A;TBC1D8;CYTH1;ADGRB3;SPATA13;TBC1D9;ARHGAP39;GMIP;ARHGAP15;ACAP2;ABR;DENND5B;HACD3;GARNL3;RAPGEF1;TBC1D1;SYDE2;TBC1D16;DOCK2;TBC1D30;SMAP2;RGS16;SIPA1;DENND1A;ELMOD1;RP2;RGS20;ARHGEF11;ARHGEF4;ARHGEF7;VAV1;ARHGAP22
prerank,proton transmembrane transporter activity (GO:0015078),-0.4118302357451268,-1.2940470399864517,0.10810810810810811,0.5072415820798734,1.0,15/39,21.55%,COX4I1;SLC33A1;UQCRH;UQCR10;COX5B;CYB5A;COX6B1;COX8A;NDUFA4;NDUFA4L2;ATP6V1F;COX6A1;UQCR11;COX4I2;COX10
prerank,O-acyltransferase activity (GO:0008374),0.5420757570676199,1.2926334950937288,0.15214180206794684,0.767156956110784,1.0,11/30,20.46%,SOAT1;MOGAT3;PLA2G15;MBOAT1;MBOAT4;DGAT2L6;LCAT;MOGAT1;LPCAT1;GPAT3;PLA2G4A
prerank,DNA-binding transcription factor binding (GO:0140297),0.43197790813816794,1.290889131721634,0.07567567567567568,0.7654063755838497,1.0,55/189,16.54%,ZFPM2;TCF7L2;HDAC4;HDAC9;HES1;WWP2;KLF4;NFE2L2;GSK3B;PRRX1;MEF2A;TXLNG;TLE2;BHLHE40;TLE6;CREBBP;ISL1;SKI;ZMYND8;STAT3;KDM1A;GATA4;DDIT3;ID2;PITX2;PIAS2;PIAS3;EGR2;DACT1;GATA1;CBX5;JUN;MTDH;NCOR1;TCERG1;MIER1;SMAD2;RB1;MTA1;HIRA;DDRGK1;TCF3;HNF4A;EP300;HCFC1;TLE3;CRTC1;NFATC1;DHX9;TLE4;ATF2;TWIST1;ZBTB7A;RBBP8;PRDM5
prerank,sodium channel regulator activity (GO:0017080),0.526386143567537,1.2889432457400372,0.19337016574585636,0.7647467495226099,1.0,8/37,5.73%,PTPN3;NEDD4;FXYD5;CAMK2D;FGF13;SGK3;ATP2B4;SNTA1
prerank,tau-protein kinase activity (GO:0050321),0.5737023342927796,1.2879894873626951,0.19908814589665655,0.7608777843168727,1.0,5/20,9.89%,MARK1;GSK3B;MARK2;SIK3;MARK3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4365864912177474,1.2853758186383017,0.08287895310796074,0.7628594049336407,1.0,48/181,15.24%,ZFPM2;TCF7L2;HDAC4;TACC2;HES1;ANXA4;WWP2;KLF4;NFE2L2;GSK3B;PRRX1;MDFIC;MEF2A;BCAS3;BHLHE40;CREBBP;ISL1;STAT3;KDM1A;GATA4;TADA3;ID2;JUP;PITX2;PIAS2;RXRA;PIAS3;EGR2;DACT1;GATA1;JUN;MTDH;NCOR1;TCERG1;MIER1;RB1;MTA1;HIRA;DDRGK1;SMARCA4;TCF3;HNF4A;EP300;NCOR2;NFATC1;DHX9;ATF2;BAZ2A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5248180193813611,1.2841944404188315,0.1879382889200561,0.7596487760273539,1.0,13/33,16.96%,ELOF1;SMYD2;SCAF8;ERCC5;WDR43;UVSSA;WAC;CTR9;DHX9;ELP4;URI1;AGO2;RECQL5
prerank,ion channel inhibitor activity (GO:0008200),0.524465373812919,1.2826899983547073,0.1887905604719764,0.7577757566029997,1.0,8/35,10.06%,KCNMB2;NEDD4;CAMK2D;WNK1;STX8;TNNI3;COMMD1;MCUB
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4888908936176337,1.2819750294513093,0.15194805194805194,0.7534546611432545,1.0,8/53,7.46%,MICAL2;AOX1;CRY2;KDM1A;MMACHC;ACOX3;AGPS;GSR
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.4762938174928467,-1.2816040355978917,0.15211267605633802,0.5196707267106194,1.0,5/21,7.04%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.4762938174928467,-1.2816040355978917,0.15211267605633802,0.5196707267106194,1.0,5/21,7.04%,CDK8;CDK14;CDK19;CDK6;CDK15
prerank,FAD binding (GO:0071949),0.5624869116592045,1.2814047584526158,0.1806853582554517,0.748590599895932,1.0,4/24,6.74%,MICAL2;CRY2;MMACHC;AGPS
prerank,protease binding (GO:0002020),0.4589166421131528,1.2776081828799881,0.13048498845265588,0.7545390172772898,1.0,19/99,11.24%,F3;SLC2A13;FN1;ANXA2;COL3A1;CRADD;ITGB1;GSK3B;SERPINB9;VCP;LDLR;ITGAV;TIMP2;RIPK2;LCOR;BRCA2;ITGB3;LONP2;TIMP1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.45033161267771904,-1.2766598840506482,0.15211267605633802,0.5226533690915186,1.0,9/24,18.22%,OSBPL8;CERT1;DAB2IP;PLEKHA5;GSDMD;JPH2;RUBCNL;LANCL2;SNX3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5665767004008087,1.2751609668267618,0.19815668202764977,0.7553892898930664,1.0,11/21,28.48%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLM;POLI;PRIMPOL
prerank,NAD binding (GO:0051287),0.5565002484298458,1.2742208424073809,0.17925925925925926,0.7520719173343614,1.0,2/26,1.78%,ME1;BDH2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6468952321922844,1.2715715294711054,0.22916666666666666,0.7542836421569502,1.0,5/10,20.81%,SMYD2;SETD2;SETD5;NSD1;ASH1L
prerank,nuclear receptor binding (GO:0016922),0.45476663631008507,1.270703482979356,0.12796208530805686,0.7506654793524301,1.0,37/111,17.78%,FOXP1;TCF7L2;DDX5;TACC2;JMJD1C;STRN;NR4A3;NR4A2;BCAS3;ISL1;ESR1;KDM1A;TADA3;TGFB1I1;TRIP12;LCOR;JUP;RXRA;MED13;NCOR1;DCAF1;NR4A1;SMARCA4;TRIP6;EP300;NCOR2;MED14;DNAAF4;BAZ2A;THRAP3;ZBTB7A;MED24;NSD1;RNF14;BRD8;GAS2L1;NCOA6
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5649890263427213,-1.2680299007008402,0.19626168224299065,0.5351762551896645,1.0,4/10,11.54%,DPP10;DPP4;PRCP;DPP6
prerank,inward rectifier potassium channel activity (GO:0005242),0.558989059044546,1.2670701969501983,0.21301775147928995,0.7560956718035777,1.0,2/24,2.72%,KCNJ2;KCNJ15
prerank,protein phosphatase 1 binding (GO:0008157),0.5622830172307602,1.2666569566483483,0.2015267175572519,0.7509958090346512,1.0,3/21,4.51%,PPP1R3B;PPP1R3C;SHOC2
prerank,DNA polymerase activity (GO:0034061),0.5584168399268707,1.260377587495167,0.21351766513056836,0.7648917696279334,1.0,11/22,28.48%,REV3L;POLB;POLE2;REV1;POLA1;POLD3;POLK;POLQ;POLM;POLI;PRIMPOL
prerank,translation initiation factor activity (GO:0003743),0.5024035780312153,1.2597622914268989,0.20562130177514792,0.7606724723304193,1.0,14/36,20.86%,EIF4G3;EIF4G1;EIF2D;MTIF3;EIF3E;COPS5;EIF4E3;EIF3A;EIF2B2;EIF2S2;AGO2;EIF2S1;EIF4G2;EIF2B3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.64190833039533,1.25939008501024,0.2286212914485166,0.7556263111718913,1.0,1/10,0.87%,DPYSL3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6238247329925075,1.2593177825234265,0.22735674676524953,0.7498314006568626,1.0,5/10,12.24%,CXADR;DSP;DSG2;JUP;DSC2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6595185885469097,1.2588551985503071,0.22142857142857142,0.7393018114991257,1.0,3/10,11.49%,DUSP16;DUSP5;DUSP10
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6595185885469097,1.2588551985503071,0.22142857142857142,0.7393018114991257,1.0,3/10,11.49%,DUSP16;DUSP5;DUSP10
prerank,phosphatase activator activity (GO:0019211),-0.5226012774309854,-1.258724857266752,0.18733509234828497,0.5503205030526519,1.0,5/14,13.41%,CALM1;FRS2;BMP2;PPP2R5A;CALM3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5515550486284022,1.25611531263404,0.21547799696509864,0.7414966738381392,1.0,8/23,9.84%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6224494641642959,1.2558218134201318,0.22456140350877193,0.7365320541972072,1.0,3/12,16.06%,CYFIP2;EIF4E3;AGO2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4675399769409182,-1.2535731407087594,0.20224719101123595,0.5544633520296607,1.0,9/19,15.60%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.42678436712916723,1.2521209563024145,0.1172566371681416,0.7421136815422088,1.0,18/173,6.37%,FOXP2;FOXP1;KLF12;ZFHX3;PLAGL1;FOXP4;FOXO3;ZBTB16;HES1;SKIL;ZNF148;NR2F1;JDP2;FOXK1;NFATC4;BHLHE40;SKI;NFIL3
prerank,filamin binding (GO:0031005),0.6177346226962743,1.2503767304515327,0.2530329289428076,0.7422408645872344,1.0,2/11,5.92%,DPYSL3;NEBL
prerank,transcription cis-regulatory region binding (GO:0000976),0.40421419567816574,1.250370096792349,0.044147843942505136,0.7366141928127224,1.0,79/406,13.96%,BNC2;FOXP1;VSX1;SIX1;TCF7L2;PLAGL1;SOX9;HDAC4;FOXN3;PBX1;CUX1;SMAD6;GLI3;FOXO3;GRHL1;TWIST2;PURG;KLF4;NFE2L2;CRY2;FOXC2;MEF2A;FOXK1;ARID4A;KLF10;ZBTB7B;ARID4B;GLIS2;ISL1;STAT3;ATF1;GATA4;DDIT3;TBL1X;NFIL3;HIF3A;E2F3;MYOG;DMBX1;BARHL2;PHOX2A;LHX2;IRF1;TEAD1;GABPB1;GABPB2;PITX2;MLXIP;RXRA;GRHL2;FOXC1;NFYA;RORA;PER3;EGR2;NFKB1;GATA1;CTCFL;RARA;JUN;ZNF25;NCOR1;PER1;SMAD2;ATF6;ZBED4;RB1;FOXK2;NKX2-1;KMT2D;TCF3;HNF1A;HNF4A;XRCC5;PAX6;CHD3;SP3;E2F2;PRDX5
prerank,phosphotyrosine residue binding (GO:0001784),0.5002248079609526,1.248757945835949,0.20714285714285716,0.7361416530075242,1.0,11/37,13.02%,PTPN3;VAV2;SHC1;ABL1;IRS1;NCK2;CBLC;BCAR3;PLCG2;PIK3R3;YES1
prerank,cadherin binding (GO:0045296),0.41025187250764955,1.248440506218201,0.07276507276507277,0.7317057825667372,1.0,79/315,13.85%,EGFR;CDH1;CDH11;FMNL2;BAIAP2L1;TES;STXBP6;CTNND2;FXYD5;EZR;AHNAK;ABI1;NDRG1;ANXA1;ANXA2;CALD1;MPP7;PHLDB2;PARVA;SPTAN1;CTNNA1;GIPC1;PLCB3;ITGB1;PAICS;FLNB;ERC1;CAST;PDXDC1;HDLBP;TMOD3;SNX2;ESYT2;STX5;VCL;CLINT1;SHTN1;CLIC1;PFKP;PDLIM5;DLG1;BZW1;PKP1;RDX;JUP;KTN1;MARK2;SH3GLB2;UNC45A;TXNDC9;P2RX4;CD46;IQGAP1;NIBAN2;ACVR1;EHD1;CCS;CTTN;EMD;SERBP1;KRT18;CAPZA1;PLEC;GAPVD1;EIF3E;GOLGA3;ADD1;LYPLA2;LIMA1;PCMT1;NOP56;EPS15L1;PKN2;PAK2;SH3GLB1;HCFC1;ARGLU1;TBC1D10A;BAG3
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5564860051810426,1.2479353052159177,0.25199362041467305,0.7280198068030188,1.0,11/20,20.56%,USP25;DESI2;USP7;USP47;COPS5;SENP5;OTUD5;USP9X;SENP3;SENP1;USP21
prerank,clathrin adaptor activity (GO:0035615),0.5859413505975505,1.2478131239475767,0.23817034700315456,0.7230159415206764,1.0,4/15,8.98%,STON1;AP2A2;STON2;AP2A1
prerank,E-box binding (GO:0070888),-0.41566626282600966,-1.2476736334476322,0.1503267973856209,0.5606653388811106,1.0,6/34,8.96%,TCF4;ZEB1;AHR;MITF;TAL1;CIART
prerank,acid-thiol ligase activity (GO:0016878),-0.5086247700557995,-1.2475552668802368,0.21844660194174756,0.5528934493530975,1.0,4/13,11.17%,ACSS3;ACSL1;ACSS1;ACSS2
prerank,calcium channel inhibitor activity (GO:0019855),-0.5387930548165759,-1.2459841757488348,0.22172949002217296,0.5487227623198123,1.0,3/11,9.55%,ITPR1;CALM1;SLC30A1
prerank,CoA-ligase activity (GO:0016405),-0.4922411292124351,-1.2455677980212998,0.2107843137254902,0.5419329250730666,1.0,5/14,15.19%,ACSS3;ACSL1;ACSS1;ACSS2;ACSBG1
prerank,diacylglycerol kinase activity (GO:0004143),-0.5426579335240325,-1.244261255905678,0.2235294117647059,0.5373132938503371,1.0,4/11,8.86%,DGKB;DGKI;DGKD;DGKG
prerank,peptidoglycan binding (GO:0042834),-0.56270036359922,-1.243346123608268,0.2219679633867277,0.532241606546687,1.0,2/10,5.37%,NOD1;PGLYRP1
prerank,triglyceride lipase activity (GO:0004806),0.5590038855769935,1.2429930099780309,0.208398133748056,0.7320730172118068,1.0,4/20,12.80%,PNPLA3;PLA2G15;DAGLB;LCAT
prerank,RNA polymerase binding (GO:0070063),0.5554154943569756,1.2413858830471922,0.23731587561374795,0.7312225916138255,1.0,7/18,14.40%,NEDD4;STOM;SCAF8;TCERG1;PKN2;PHRF1;DHX9
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5911668651990849,1.2412503413747562,0.25121555915721233,0.7264012672920935,1.0,5/13,21.66%,PNPLA3;LCLAT1;LPCAT1;GPAT3;ABHD5
prerank,lysine N-methyltransferase activity (GO:0016278),0.5518944722633474,1.24032116227079,0.2453416149068323,0.7238709816481521,1.0,11/20,26.77%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;SETD6;METTL21C;EEF1AKMT4
prerank,voltage-gated potassium channel activity (GO:0005249),0.4520550597600498,1.24003356507644,0.16708229426433915,0.7196269098190878,1.0,6/80,3.00%,KCNB2;KCNJ2;KCNQ5;KCNJ15;KCNS3;KCNB1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4600216346117724,1.2383859256518452,0.1853720050441362,0.7191736000676928,1.0,15/71,8.90%,EYA2;PTP4A2;PTPN3;PTPRU;UBASH3B;EYA4;PTPRF;PTPDC1;PTPN2;PTPRA;CDC25B;EYA3;PTPN21;DUSP11;CDC14A
prerank,death receptor activity (GO:0005035),-0.5255220398315714,-1.236135216894148,0.23514851485148514,0.5419322104538329,1.0,3/11,7.12%,TNFRSF19;FAS;TNFRSF11A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5062073330502488,-1.23241411067481,0.21483375959079284,0.5435548105933623,1.0,6/14,16.76%,CTSH;NOD1;MAL;ATP2A3;RACK1;CASP1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.48744898348497295,-1.2306211020466522,0.2096317280453258,0.5404537996012492,1.0,9/17,10.73%,GRIA4;GRIK2;GRIN2A;GRIN2B;GRIK1;GRIA3;GRIN1;GRIA2;GRIA1
prerank,fibroblast growth factor binding (GO:0017134),0.5508612574924739,1.229894739116237,0.23125996810207336,0.7384949749860782,1.0,3/21,5.85%,THBS1;FGFR1;ITGAV
prerank,receptor ligand activity (GO:0048018),0.406765165956688,1.2277547920735672,0.11513859275053305,0.7391901790360942,1.0,40/245,11.81%,BMP4;TNFRSF11B;WNT9A;OSGIN2;BMP5;NGF;EDA;PGF;TGFB3;SEMA3E;WNT11;SEMA3D;SEMA3C;BMP6;INHBA;FGF2;LRPAP1;FAM3C;CLCF1;DEFB130A;WNT16;GDNF;PTHLH;SLURP1;JAG1;GDF6;IL10;GDF5;NBL1;PDGFA;GDF10;CTF1;IL33;C1QTNF12;VEGFA;CCL3;TIMP1;ERFE;INHBB;FGF22
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5990999600672162,1.227350834241721,0.24052718286655683,0.7352078094626646,1.0,4/12,11.16%,SULF1;ARSI;ARSB;SGSH
prerank,RNA cap binding (GO:0000339),0.5769201719584977,1.2271241585329764,0.23432343234323433,0.7308260254335942,1.0,1/16,0.98%,CYFIP2
prerank,SH3 domain binding (GO:0017124),0.4559391842593541,1.2206869223620758,0.1927554980595084,0.7442997179068674,1.0,11/62,9.16%,AFAP1L1;DPYSL3;ABI1;ADAM9;ABL1;ADAM12;PLSCR1;CBLC;SHANK1;RUFY1;AFAP1
prerank,rRNA binding (GO:0019843),-0.37566054874475896,-1.220451058389931,0.1543859649122807,0.5570840825282662,1.0,16/42,27.27%,RPS14;RPS9;RPS13;RPS3;RPS5;RPL23;RPL11;FASTKD2;MRPS11;RPL12;RPL5;EMG1;RCC1L;RPLP0;RRS1;DDX28
prerank,endodeoxyribonuclease activity (GO:0004520),0.5482950750116429,1.2202595285070352,0.24170616113744076,0.7404338877490967,1.0,9/20,22.86%,EXO1;ERCC5;APLF;APEX1;RBBP8;ERCC1;RAD50;MBD4;EXOG
prerank,CoA hydrolase activity (GO:0016289),0.5737128973558199,1.2177545752692007,0.26151315789473684,0.7426435182708255,1.0,9/16,25.07%,ACOT8;HIBCH;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11;NUDT7;ACOT6
prerank,serine-type endopeptidase activity (GO:0004252),0.44618942471015666,1.216887913563108,0.18811881188118812,0.740194767678806,1.0,3/80,4.72%,F3;PCSK5;PRSS12
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5222343343330372,1.2123027722395456,0.26426426426426425,0.748408653005903,1.0,2/25,1.98%,MICAL2;FMO1
prerank,SUMO binding (GO:0032183),0.5970316494706568,1.2121857464122472,0.2945990180032733,0.7437658879632192,1.0,7/13,22.14%,HERC2;USP25;SERBP1;RNF111;PML;TDG;CASP8AP2
prerank,DNA binding (GO:0003677),0.38783218311931983,1.207753661018723,0.055220883534136546,0.7519497844445258,1.0,163/694,19.08%,FOXP2;EGFR;KLF12;TCF7L1;SIX1;TCF7L2;SLTM;PLAGL1;RARB;NFIB;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;PBX1;CUX1;FOXO3;MEOX2;ZBTB16;HES1;GRHL1;COLEC11;ESR2;MPG;NFE2L2;ZNF148;CRY2;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;EHF;NR4A3;FOXL1;NR4A2;HDGFL3;RNF138;ARID4A;RBM6;CREBBP;STAT3;C1D;MBD1;GATA4;DDIT3;CEBPZ;E2F3;EXO1;SLPI;MYOG;DMBX1;NOBOX;SOX14;CCDC25;IRF1;TEAD1;STN1;ERCC5;MCM7;CAMTA2;RXRA;ZNF8;GRHL2;FOXC1;NFYA;RORA;GLI2;WRN;EGR2;BCLAF1;GATA1;CTCFL;MCM2;RARG;RAD23B;TOP1;CHTF18;JUN;APEX1;CARF;FOXE1;CLSPN;BRCA2;TRIM26;ZBTB32;IGHMBP2;NABP1;SMAD2;ATF6;DDX11;BPTF;FOXK2;ZMYM4;CBFB;SMC1A;NKX2-1;RAD52;NR4A1;CDC45;NR6A1;ZC3H12A;SMARCA4;KMT2D;TCF3;HNF1A;HNF4A;PRKDC;RFX2;XRCC5;PAX6;EP300;CHD3;E2F2;POLG2;DHX9;FOXD2;DNMT3A;TLR8;MCM9;KIN;HINFP;ERCC3;TFAP2A;THRAP3;ZNF219;ZBTB7A;TRIM16;BCL6;CALCOCO1;TAF12;RBBP8;POU6F1;XPA;PRDM5;YY1;RPA1;ZNF76;TOP3A;TAF4;SREBF1;NBN;TSG101;TSHZ2;RAD51;ERCC1;POLR3F;KHDRBS1;EZH1;NEIL3;SMARCA5;AIFM2;DHX36;QRICH1;INO80;WDR48;PPARG;RFX5;CIITA;RFC1;CCNT1;AIFM1
prerank,protein serine/threonine kinase activity (GO:0004674),0.39190660028003194,1.2058040405611068,0.10754912099276112,0.7527201760450225,1.0,78/334,15.45%,STK39;EGFR;MAP3K5;GRK5;MARK1;PTK2B;CIT;CAMK2D;WNK1;PRKCD;ULK2;CLK1;LIMK2;HIPK1;ALPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;BCR;TGFBR1;CLK2;MKNK2;STK16;TGFBR2;SGK3;STK35;GAK;TRIO;IRAK4;CDK12;RIPK2;VRK3;FAM20A;MARK2;IKBKE;CHEK2;PLK3;CSNK1A1;CSNK1G3;NLK;RIPK3;CHUK;AAK1;AURKA;SIK3;MARK3;SIK2;IRAK3;ACVR1;PIM2;ATM;TOP1;MAPK12;MAST2;HTATIP2;CDKL2;CPNE3;PDK3;MTOR;CSNK1G1;CHEK1;SMG1;PKN2;PAK2;PRKDC;CSNK1E;ERN2;CDC42BPG;DYRK2;EIF2AK4;CDK11B;MAPKAPK2;PRKCA;CDK16;SQSTM1;CLK4
prerank,metalloaminopeptidase activity (GO:0070006),0.564714948428172,1.2051872953527012,0.25549915397631134,0.7497039689217742,1.0,6/16,11.29%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1
prerank,MHC protein binding (GO:0042287),-0.45262973724049665,-1.2044236248015758,0.21750663129973474,0.588210113721344,1.0,8/20,22.00%,ATP5F1B;CD81;TAP2;ATP5F1A;CD74;ABCB9;TUBB4B;TAPBP
prerank,chloride channel inhibitor activity (GO:0019869),0.6087640950071805,1.204244157797376,0.2808586762075134,0.7474572029664095,1.0,2/10,9.28%,WNK1;STX8
prerank,endopeptidase inhibitor activity (GO:0004866),-0.3239199576987442,-1.2041398609870246,0.08290155440414508,0.5815723700123485,1.0,15/82,8.94%,COL4A3;TIMP3;SPOCK2;PROS1;SPOCK3;SERPINI1;CST3;ITIH2;SPOCK1;APP;TFPI;BST2;SERPIND1;GAPDH;A2M
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.4120693198633403,-1.2040493629041744,0.22435897435897437,0.5746077774052967,1.0,9/28,15.60%,GRID2;GABRG3;GRIK2;GABRA2;GRIK1;GABRA1;GABRG1;GABRA4;GABRA5
prerank,potassium ion leak channel activity (GO:0022841),0.5711033302731691,1.2039126835369471,0.2803149606299213,0.7435500151588108,1.0,1/15,0.19%,KCNK5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5333924547609352,-1.2010293489652526,0.25552825552825553,0.5746638358103326,1.0,4/10,9.80%,APOBEC1;ADARB2;LACC1;GDA
prerank,iron ion binding (GO:0005506),0.47722182520883394,1.1989902867939801,0.21428571428571427,0.7530088768496844,1.0,8/48,11.91%,AOX1;EGLN3;FDX1;FTO;TYW5;SCD;CDO1;ALKBH8
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4402949265043293,1.1968859414271322,0.2315653298835705,0.7541977219117845,1.0,4/75,2.10%,ME1;EHHADH;BDH2;ADH7
prerank,leak channel activity (GO:0022840),0.5527244392317723,1.195991902778074,0.2714285714285714,0.7521863850660981,1.0,2/18,4.49%,KCNK5;NALCN
prerank,poly(A) binding (GO:0008143),-0.43828482367839566,-1.1936922695285066,0.2551928783382789,0.5850665968945978,1.0,4/21,6.82%,RBPMS;RBMS1;KHDRBS2;ELAVL4
prerank,calcium ion binding (GO:0005509),0.3842296657127762,1.1936656373163879,0.13388259526261587,0.7540989379915467,1.0,32/323,7.51%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;ACER3;CDH11;ESYT3;PPP3CA;ANXA1;ANXA3;ANXA2;DSPP;GSN;ANXA4;COLEC11;DSG2;GLCE;ESYT2;PLA2G4F;TRPM4;STIM2;ITPR2;LRP1;CASR;PLSCR1;CRACR2A;LTBP4;OC90;TGM3;S100G;SYT8
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3441489711176197,-1.1924305196712992,0.16883116883116883,0.5807543953891329,1.0,28/60,14.46%,FLT1;IGF1R;TEK;PDGFRB;MERTK;KIT;EPHA7;TIE1;KDR;EPHB1;INSR;ROR2;ERBB4;EPHA4;EPHB4;EPHA8;EPHA6;NTRK2;PDGFRA;FGFR4;AXL;FLT4;LMTK2;TYRO3;MUSK;EPHA5;CSF1R;ACVRL1
prerank,NF-kappaB binding (GO:0051059),0.5207369434424763,1.1904721799310796,0.25948406676783003,0.7582574667251086,1.0,6/24,17.17%,ANXA4;GSK3B;MTDH;EP300;CPNE1;BCL10
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.44419164638452574,1.1890619898234671,0.24324324324324326,0.757351230637839,1.0,10/72,4.52%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1
prerank,damaged DNA binding (GO:0003684),0.47288806246509607,1.1860704811682181,0.24664879356568364,0.7610914475094308,1.0,15/44,20.66%,MPG;CRY2;CREBBP;ERCC5;APEX1;EP300;ERCC3;RBBP8;XPA;RPA1;NBN;ERCC1;NEIL3;SMC6;TDG
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4382690574631014,1.1833765347638208,0.23195876288659795,0.7642588124452748,1.0,19/78,12.28%,CAPN5;USP46;USP2;USP13;CAPN2;USP24;CASP6;CAPN6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;CAPN10;USP47;CAPN12;USP33
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.41649406150300117,-1.183209854029433,0.23306233062330622,0.5959325064252988,1.0,13/23,17.93%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A;PDE9A;PDE3B;CNP
prerank,amyloid-beta binding (GO:0001540),0.4306420348685155,1.1818677921132892,0.24387254901960784,0.7638192940047308,1.0,9/79,8.76%,COL25A1;ADRB2;LRPAP1;ITM2C;LDLR;LRP1;CLU;TLR4;ATP1A3
prerank,phosphatidate phosphatase activity (GO:0008195),0.5604299977542156,1.1815194742943906,0.265139116202946,0.7602659484978596,1.0,2/13,2.22%,PLPPR2;PLPP3
prerank,estrogen receptor binding (GO:0030331),-0.39204467530203513,-1.1810465428525374,0.21036585365853658,0.5935706257025103,1.0,5/32,5.36%,LEF1;TACC1;NCOA1;PPARGC1B;RERG
prerank,magnesium ion binding (GO:0000287),0.40302963664652,1.1784942493269805,0.20426487093153758,0.764201157366397,1.0,35/135,20.66%,EYA2;MAP3K5;MARK1;GCLC;ABL1;PLSCR1;DXO;MARK2;NLK;WRN;SIK3;SIK2;IRAK3;NUDT5;MAPK12;HACL1;MAST2;FOXK2;ERN2;CDC42BPG;DYRK2;PLSCR3;CLYBL;NUDT12;DIS3L2;CDC42BPA;SRPK1;DHX36;RHEB;NEK6;DYRK3;RAN;EXD2;PDXP;TDG
prerank,pre-mRNA binding (GO:0036002),0.49391299703584624,1.1777004726049916,0.2948905109489051,0.7616620680694299,1.0,11/28,25.76%,DDX5;SRSF6;CELF1;CELF3;U2AF2;RNPC3;U2AF1L4;TRA2B;RBM4;CELF4;ERI1
prerank,fatty acid synthase activity (GO:0004312),-0.5139569056594402,-1.1776885226141778,0.27918781725888325,0.5944179809618848,1.0,3/10,11.39%,ELOVL7;ELOVL6;ELOVL4
prerank,phospholipase C activity (GO:0004629),0.5150694814672859,1.1771264138401267,0.2846270928462709,0.7586596593177299,1.0,8/25,9.84%,PLCE1;EDNRA;PLCB3;PLCZ1;CHRM5;CASR;PLCD3;PLCG2
prerank,ion channel activity (GO:0005216),0.4286102256130414,1.1764391301762862,0.23067484662576687,0.756007439881415,1.0,12/80,7.58%,PIEZO2;TMEM120A;TMC6;TRPM6;NALCN;TRPM4;TMC1;CALHM5;TRPM7;P2RX2;CALHM2;GRIK4
prerank,single-stranded DNA helicase activity (GO:0017116),0.5408562939727443,1.1763024417462453,0.29141104294478526,0.7519475270488565,1.0,11/19,28.32%,MCM7;MCM2;CHTF18;DHX9;CHTF8;RAD51;HELB;DSCC1;RFC5;POLQ;MCM6
prerank,myosin II binding (GO:0045159),0.5980386052520709,1.1718510478258364,0.2979094076655052,0.7597606359484044,1.0,6/10,24.12%,GSN;SHROOM4;TRIOBP;LLGL1;MYL4;STXBP5
prerank,WW domain binding (GO:0050699),-0.401133962485526,-1.168837739496933,0.25348189415041783,0.6082035750478766,1.0,7/26,15.88%,RAPGEF2;TNK2;LITAF;TCEAL9;NDFIP2;ENAH;DAZAP2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4231894872879937,-1.1667250263654891,0.23641304347826086,0.6061454301648737,1.0,10/21,12.83%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4D;PDE2A;PDE4A;PDE8A;PDE4C;PDE1A
prerank,tropomyosin binding (GO:0005523),0.5474702145974,1.1651387631961174,0.3113673805601318,0.774611675181063,1.0,3/16,5.92%,CALD1;TMOD3;NEBL
prerank,neurexin family protein binding (GO:0042043),0.5879180302373894,1.1642236848388425,0.3161397670549085,0.772668239739207,1.0,2/10,4.45%,SYTL5;SYTL4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5148958360958624,1.1619468143211327,0.3022556390977444,0.7746056910506967,1.0,10/22,16.37%,TAB3;IKBKE;OTUD7B;WDR81;UIMC1;ZRANB1;RNF168;ZBTB1;SQSTM1;IKBKG
prerank,alkali metal ion binding (GO:0031420),-0.4726007936441537,-1.160972163861608,0.27671232876712326,0.6127923401145818,1.0,1/13,0.02%,ATP1A2
prerank,protein tyrosine kinase activity (GO:0004713),-0.3064538315832387,-1.159226625770953,0.10687022900763359,0.610249189853615,1.0,40/108,15.83%,FLT1;IGF1R;LYN;TEK;PEAK1;PDGFRB;MERTK;KIT;EPHA7;TIE1;KDR;EPHB1;TEC;INSR;ROR2;ERBB4;EPHA4;TNK2;EPHB4;EPHA8;PTK2;EPHA6;NTRK2;BMX;AATK;PDGFRA;FGFR4;AXL;FLT4;FES;LMTK2;TYRO3;MUSK;EPHA5;CSF1R;TTBK1;JAK3;HCK;FLT3;HIPK3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5144121654477222,-1.1586865294797646,0.32598039215686275,0.6048840867479822,1.0,6/10,15.60%,GABRG3;GABRA2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,ankyrin binding (GO:0030506),0.5105647988854565,1.1549025705256868,0.31511254019292606,0.7895286501524797,1.0,1/19,0.33%,CDH1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5645877194728521,1.1547234155249524,0.31886477462437396,0.7854867640760061,1.0,2/13,11.67%,EHHADH;EBP
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.41833483755672435,1.1516243679105476,0.26290516206482595,0.7900028554270245,1.0,17/91,9.74%,KCNJ2;VILL;MARK1;STXBP6;ANXA2;GSN;PLEKHA4;FZD7;SNX18;PLCZ1;WIPI2;RLBP1;GBF1;SLC9A1;PARD3;FCHO2;COMMD1
prerank,protein tyrosine kinase binding (GO:1990782),-0.33054828164008,-1.1473845570735053,0.20754716981132076,0.6247955807547114,1.0,27/71,21.08%,NRG3;DOCK4;GRM5;GRB14;CBLB;NEDD9;EPHA4;SIRPA;ANGPT2;SOCS5;GAS6;BLNK;SHC3;DUSP3;SHC4;NOX4;SH2B3;RACK1;ARHGEF16;FLT3LG;CDH5;TJP2;HYAL2;TREM2;NRG1;ANGPT4;PHYHIP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4393430444909427,1.146281277561274,0.2813333333333333,0.8006504728921306,1.0,5/54,5.36%,ACER3;HDAC4;HDAC9;VNN1;HDAC8
prerank,chloride channel regulator activity (GO:0017081),0.5455581744566451,1.1438477472174,0.33114754098360655,0.8029562415660537,1.0,3/14,9.28%,WNK1;SGK3;STX8
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4681642508436042,-1.143712757254688,0.2915601023017903,0.6264041035401324,1.0,6/14,22.82%,ALDH1L1;BLVRB;ALDH4A1;QDPR;AASS;PYCR2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4975061548465821,1.1428283622346003,0.3264094955489614,0.8013977123152307,1.0,4/24,4.74%,PTK2B;CAMK2D;PHKA2;MKNK2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.5372619532101498,1.1427785934790846,0.33170731707317075,0.797107546030557,1.0,10/15,35.22%,PNPLA3;LCLAT1;LPCAT1;GPAT3;ABHD5;ABHD4;LPCAT2;GPAT4;AGPAT5;AGPAT2
prerank,growth factor activity (GO:0008083),0.42093691823112717,1.1411355838027128,0.27875,0.7970998812145643,1.0,10/74,7.95%,OSGIN2;NGF;PGF;INHBA;FGF2;CLCF1;GDNF;JAG1;IL10;PDGFA
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5204488556281573,1.1400503360514644,0.31726283048211507,0.7956936958731591,1.0,4/17,9.94%,BDH2;DECR1;PECR;LBR
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3907126698442571,-1.1380875900414889,0.3026706231454006,0.6329013345125926,1.0,6/28,8.87%,TNK2;MAP2K6;PRKAA2;SGK1;RPS6KA1;PAK3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5104282792369491,1.1365790507530846,0.3171875,0.8011911615215879,1.0,7/18,11.05%,TGFB3;SMAD6;TGFBR1;TGFBR2;BAMBI;USP15;SMAD2
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4117735148411522,-1.1334689112078418,0.288,0.6377500573424846,1.0,8/22,16.15%,SCN7A;HCN1;SCN1A;SCN3A;CACNA1I;HCN2;SCN2A;SCN9A
prerank,protein phosphatase activator activity (GO:0072542),-0.4746767927292829,-1.1315702163716568,0.3082706766917293,0.6351840987819869,1.0,4/13,13.41%,IGFBP3;CALM1;PPP2R5A;CALM3
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5453074987637824,1.1312451674534485,0.342327150084317,0.8117431712002153,1.0,3/13,3.24%,SOX9;EZR;GSK3B
prerank,snoRNA binding (GO:0030515),0.4773080016024425,1.1310706931263963,0.3185840707964602,0.8079087278415046,1.0,16/30,27.91%,BMS1;NUDT4;NUDT5;UTP6;NOP56;PRKDC;XRCC5;DDX21;WDR3;BYSL;NUDT1;NOP58;NUDT7;IMP4;TSR1;NUDT16L1
prerank,N-methyltransferase activity (GO:0008170),0.49958471392371157,1.130582023864309,0.324031007751938,0.8050677934652813,1.0,4/20,17.45%,RNMT;NNMT;GNMT;METTL15
prerank,3'-5' exonuclease activity (GO:0008408),0.439845089285398,1.1296341654889956,0.2892223738062756,0.8033189728016116,1.0,25/45,32.48%,REV3L;ERI3;WRN;APLF;APEX1;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;TATDN1;RAD50;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;REXO4;DIS3;EXD1;EXOSC3
prerank,acetyltransferase activity (GO:0016407),0.4748089868437774,1.1284536003457457,0.31746031746031744,0.8022061842316454,1.0,16/31,28.62%,KAT6B;CREBBP;ELP3;PAFAH1B2;LCAT;EP300;KAT2B;NAA15;SAT1;GTF2B;NAT10;ESCO1;NAA50;NAA80;KAT6A;PAFAH1B3
prerank,histone acetyltransferase binding (GO:0035035),0.5171770910150366,1.1282279898632046,0.3167202572347267,0.7987498869041599,1.0,7/21,16.01%,GLI3;MEF2A;BCAS3;KANSL1L;KANSL1;PAX6;ZBTB7A
prerank,vinculin binding (GO:0017166),0.5558173382205714,1.1277706058470758,0.3333333333333333,0.7959407825513171,1.0,3/11,5.27%,SORBS3;CTNNA1;DMD
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4717000868044171,-1.1273811795194988,0.3131067961165049,0.6391641984994003,1.0,3/12,1.09%,LTBP1;ENG;TGFBR3
prerank,single-stranded RNA binding (GO:0003727),0.4488798913448069,1.1273028293512732,0.2871287128712871,0.7930007820116799,1.0,12/43,20.05%,STRBP;ZFR;L1TD1;U2AF2;DDX11;IFIH1;DHX9;TLR8;AGO2;JMJD6;EIF4B;FMR1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5088519050187,-1.1262950397231593,0.3480392156862745,0.6349216991523394,1.0,2/10,4.04%,MECOM;PRDM16
prerank,sialyltransferase activity (GO:0008373),-0.42508589030625393,-1.1242466319286413,0.3011049723756906,0.6331352411137863,1.0,9/20,9.30%,ST6GALNAC3;ST6GAL1;ST3GAL1;ST3GAL6;ST8SIA4;ST3GAL3;ST8SIA6;ST8SIA1;ST6GALNAC2
prerank,small GTPase binding (GO:0031267),0.37951999561525296,1.1238890365570497,0.2684268426842684,0.7982252553326564,1.0,30/169,10.17%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;DOCK7;UNC13B;ERC1;MLPH;SRGAP2;PDE6D;HPS4;RAB11FIP3;ANKRD27;RAPGEF6;OCRL;MYCBP2;RGP1;EXOC5;FGD6;RAB3GAP2;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,ubiquitin binding (GO:0043130),0.41548900353137685,1.122614991577697,0.3132832080200501,0.7975471974033849,1.0,25/73,24.73%,NEDD4;USP13;DDI2;RNF185;USP25;RAD23B;MVB12B;USP33;RNF168;NPLOC4;CXCR4;SQSTM1;IKBKG;TSG101;NBR1;WDR48;UBE2N;RNF31;TOM1L1;RBCK1;FAF2;UBAP1;ADRM1;BUB3;ASCC2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5605400332874206,1.1209245350093242,0.3585237258347979,0.7979526979589653,1.0,4/10,21.33%,EXO1;APEX1;EXD2;TATDN1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4622053751478769,1.1184339327135908,0.3058321479374111,0.8004912052191573,1.0,12/34,26.77%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;KMT5B;EEF1AKMT1;METTL21A;SETD6;METTL21C;EEF1AKMT4
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4712758631207351,1.1164367812954434,0.3323529411764706,0.8019435054628462,1.0,9/29,17.63%,ABL1;DUSP16;DUSP5;ATF7;DUSP10;NFATC1;TNIP1;MAPKAPK2;NBR1
prerank,protein phosphatase 2A binding (GO:0051721),-0.3993859717708153,-1.115432244402505,0.2914285714285714,0.647416694602749,1.0,8/23,14.75%,MFHAS1;FOXO1;DAB2IP;CTTNBP2NL;MAPT;SPHK1;GRIN3A;SMG7
prerank,pseudouridine synthase activity (GO:0009982),0.5432825521602317,1.1151250525450043,0.37152209492635024,0.8013638466797633,1.0,8/13,30.74%,PUS10;RPUSD4;PUS7L;RPUSD1;PUSL1;TRUB2;PUS7;RPUSD2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.41934634018913725,1.1128840613634166,0.31322207958921694,0.8031781285110481,1.0,9/60,4.26%,EGFR;CRIM1;MET;NTRK3;DDR2;FGFR1;NRP1;IGF2R;EFEMP1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.42853596761783724,1.1119341840060344,0.3272490221642764,0.8018094216733996,1.0,8/55,5.98%,SLC24A3;PKD1;ATP2C2;ANXA2;PKD2L2;ATP2B4;ITPR2;TRPM7
prerank,calcium channel activity (GO:0005262),0.406497766293403,1.111663856972631,0.3112745098039216,0.7985585904371829,1.0,17/84,11.94%,SLC24A3;PKD1;CACNA1C;ANXA2;CACHD1;TRPM4;TMC1;PKD2L2;STIM2;ITGAV;TRPM7;CACNG6;CACNA1F;P2RX4;MCU;SEC61A1;ORAI3
prerank,chemorepellent activity (GO:0045499),-0.39105849323955877,-1.110932097472283,0.3096590909090909,0.6520567041618678,1.0,10/25,12.23%,SEMA6A;NRG3;EPHA7;SEMA7A;SEMA6D;DPP4;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,BMP binding (GO:0036122),-0.4888522771808923,-1.1100321254744607,0.3569682151589242,0.6479185975429393,1.0,2/11,2.03%,ENG;GREM2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.47933236527995443,1.109885559068195,0.32028985507246377,0.7991682411887601,1.0,5/26,3.83%,SLC5A6;SLC16A9;SLC16A1;ABCG2;SLC26A6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5257624147221464,1.1085733194954805,0.36617405582922824,0.7988283235823889,1.0,1/14,2.10%,ADH7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.46809517221937524,-1.1061322826945077,0.3231132075471698,0.6502947121064674,1.0,5/12,16.76%,CTSH;NOD1;ATP2A3;RACK1;CASP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5423154769376857,1.1056452396610998,0.3702479338842975,0.8030812168632092,1.0,5/12,16.67%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.41820338921986017,-1.1050274033526937,0.33242506811989103,0.6463794837412001,1.0,3/18,1.09%,LTBP1;ENG;TGFBR3
prerank,potassium channel regulator activity (GO:0015459),0.4322762795728933,1.1026373474012685,0.33557046979865773,0.8068730758222766,1.0,7/49,6.71%,KCNMB3;KCNMB2;WNK1;ADRB2;KCNS3;SGK3;DLG1
prerank,telomeric DNA binding (GO:0042162),0.46180224374549533,1.102549522354858,0.35437589670014347,0.8031541595492625,1.0,12/32,21.97%,SMG6;TELO2;KDM1A;STN1;WRN;APEX1;SMG1;XRCC5;RPA1;UPF2;RAD50;TEN1
prerank,exopeptidase activity (GO:0008238),-0.33269622173024593,-1.1021197120265418,0.2786259541984733,0.6468566320259247,1.0,15/50,14.56%,CTSH;ACE;DPP10;DPP4;ENPEP;CTSA;CTSZ;PRCP;ACE2;DPP6;TRHDE;MME;LTA4H;ZMPSTE24;RNPEP
prerank,voltage-gated ion channel activity (GO:0005244),-0.45889982705079774,-1.0997978769629602,0.3373493975903614,0.6457042739043257,1.0,3/14,3.92%,CACNA1E;KCND2;HCN1
prerank,CARD domain binding (GO:0050700),0.5386279217847644,1.0973991253289344,0.3826955074875208,0.813233909368145,1.0,3/14,6.35%,CARD14;MAVS;RIPK2
prerank,low-density lipoprotein particle binding (GO:0030169),0.5128731301660336,1.0938746851993877,0.3717105263157895,0.8190356846001414,1.0,2/16,5.60%,THBS1;LDLR
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4641959457294097,-1.0928322609735879,0.3469879518072289,0.6559776427794889,1.0,9/12,46.04%,ELOVL4;GPR88;RRH;GPR52;OPN3;OPN5;OPN1SW;GNAT2;OPN4
prerank,carboxy-lyase activity (GO:0016831),0.4720754346664421,1.0897433349318961,0.35098335854765506,0.826179210264171,1.0,9/23,23.43%,CSAD;ECHDC1;MVD;PPCDC;AZIN1;ACOD1;UMPS;ODC1;GGCX
prerank,metal ion binding (GO:0046872),0.3488100665565312,1.089512933151457,0.26417004048583,0.8229173936514546,1.0,57/477,11.59%,SLIT3;SLIT2;SMOC2;THBS1;CDH1;EYA2;ACER3;CDH11;MAP3K5;ESYT3;MARK1;PPP3CA;ANXA1;ANXA3;ANXA2;DSPP;GSN;ANXA4;GCLC;COLEC11;DSG2;GLCE;ABL1;ESYT2;PLA2G4F;TRPM4;STIM2;ITPR2;LRP1;CASR;PLSCR1;CRACR2A;LTBP4;OC90;TGM3;S100G;SYT8;DXO;MARK2;NLK;S100A10;IQGAP1;WRN;C2CD5;SIK3;PCLO;S100A2;SIK2;IRAK3;APEX1;NUDT5;MAPK12;TRIM26;HACL1;MAST2;FOXK2;DSG3
prerank,MAP kinase phosphatase activity (GO:0033549),0.5500898755844781,1.0877801293362477,0.3975694444444444,0.8239058047309621,1.0,3/12,11.49%,DUSP16;DUSP5;DUSP10
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3956498714688317,-1.0856848201351477,0.33707865168539325,0.6669038129648255,1.0,6/21,19.92%,GRM5;GRM1;GRIA1;ANXA9;CHRNA7;CHRFAM7A
prerank,transition metal ion binding (GO:0046914),0.3532964909497398,1.0853025802956717,0.2808641975308642,0.8265522283200747,1.0,80/397,14.41%,ME1;AOX1;ACER3;ZFPM2;TES;HDAC4;MPPED2;ADH7;KLF4;NPEPPS;LARGE1;ABL1;HHIP;EEA1;KLF7;SEC24B;FDX1;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;SKI;ARIH1;MNAT1;TIMP2;ZMYND8;MBD1;PLA2G15;XPNPEP1;ADA;B4GALT1;IDE;PLSCR1;CBLC;TNP2;MYCBP2;XPNPEP3;ZMYM2;MDM4;RXRA;ZNF8;P2RX4;TYW5;GLI2;WRN;SCD;COMMD1;LIMS1;CCS;SEC23A;SCO2;ZBTB32;CUTC;ZDHHC15;TIMP1;ERAP1;ADAMTS3;SMPDL3A;MSRB2;ALKBH8;CZIB;USP33;CHORDC1;IFIH1;ARIH2;CHD3;UBA5;TK1;DYRK2;PLSCR3;LARGE2;PITRM1;MGAT1;RNF2;NFU1;ECE1;HDAC10;S100B;SEC24D
prerank,Wnt-activated receptor activity (GO:0042813),0.5158385530263809,1.0823662209835168,0.37898089171974525,0.8303620264038317,1.0,5/15,10.84%,PKD1;FZD7;FZD1;ROR1;LRP5
prerank,voltage-gated cation channel activity (GO:0022843),0.3855219626589838,1.0817931717480256,0.33456334563345635,0.8278548188221417,1.0,11/97,7.26%,KCNB2;CACNA1C;PTK2B;KCNQ5;KCNS3;CACHD1;KCNB1;TMC1;ITGAV;CACNG6;CACNA1F
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4473031152610641,1.080783710205984,0.3698224852071006,0.8266909009485651,1.0,13/35,25.70%,FOXP1;KLF10;TAF1C;SMARCA4;BAZ2A;AGO2;TAF4;POU2F1;NR3C1;UBTF;GTF2B;RRN3;ZBTB17
prerank,protein kinase binding (GO:0019901),0.34934841388876114,1.080486841212648,0.29255861365953106,0.8237303791198455,1.0,67/479,10.07%,SLC12A7;SLC12A2;TCF7L2;GRK5;PKD1;SOX9;ANK2;CCNA2;EZR;CIT;WNK1;ADAM9;PRKCD;FOXO3;HDAC9;UNC5C;DSP;SHC1;ITGB1;CNTLN;GSK3B;RHOBTB1;ABL1;IRS1;AP2A2;NELL1;SPRED2;NR4A3;ACSL3;TELO2;PTPN2;RNF138;BECN1;DNAJC3;SKI;IRAK4;ESR1;ITGAV;STAT3;MAVS;PFKFB2;PDLIM5;CDC25B;NBEA;DLG1;NSF;CHEK2;DUSP16;CDKN1B;IBTK;DUSP5;AP2A1;RHOA;IQGAP1;RND3;TNNI3;AURKA;DACT1;PPEF2;PLCG2;ATF7;RARA;IRAK3;ACVR1;RB1CC1;LIMS1;PPP1R12A
prerank,frizzled binding (GO:0005109),0.44847443890069166,1.08014170456284,0.36312849162011174,0.821000059391779,1.0,7/34,8.00%,WNT9A;LRP6;WNT11;FZD7;WNT16;BAMBI;FZD1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.449734551236164,1.0783453580938092,0.3922413793103448,0.8218904270826995,1.0,12/34,13.37%,CYTH3;ARAP1;GAB2;ZFYVE1;ARAP2;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;FCHSD2;DAPP1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.45920326186648974,1.078102200471287,0.37518463810930575,0.8188470484092976,1.0,9/28,22.14%,EDA;FEM1B;MYD88;TRAF5;TNFSF11;PIDD1;TRAP1;TRAF3;CASP8AP2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4512939843121949,-1.0779709497045513,0.36626506024096384,0.6786714932015364,1.0,3/12,3.90%,IGF1;PIK3R1;INSR
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4244713314353833,1.0753018691285903,0.37733333333333335,0.8221704689580075,1.0,10/49,9.64%,ESYT3;ANXA1;ANXA3;ANXA2;ANXA4;ESYT2;PLA2G4F;SYT8;C2CD5;PCLO
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.427118222191152,-1.0752651810514684,0.3619791666666667,0.6789699204583548,1.0,4/15,12.92%,PIK3R1;PIK3R6;SOCS5;PIK3R5
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.35904638675074774,-1.0745626351611854,0.3557692307692308,0.6744936018821369,1.0,11/30,18.52%,SLC30A10;SLC39A10;SLC40A1;SLC39A8;SLC30A1;SLC31A1;SLC30A4;TTYH1;SLC39A1;SLC39A7;ATP7A
prerank,histone deacetylase binding (GO:0042826),0.3899427760055867,1.074505060088099,0.3616504854368932,0.8204608278494105,1.0,30/88,24.18%,HDAC4;GLI3;HDAC9;HES1;MEF2A;LCOR;CAMTA2;DACT1;NCOR1;MIER1;MTA1;NIPBL;KAT2A;PKN2;NCOR2;HDAC10;CCND1;KAT2B;DHX36;BRMS1L;MAPK8;SATB2;MIER2;THAP7;BEX4;MEF2D;AKAP8L;BRMS1;NUDT21;CIR1
prerank,endopeptidase regulator activity (GO:0061135),-0.3507622801641026,-1.0726724955746092,0.31448763250883394,0.6729466979550788,1.0,14/40,22.24%,PROS1;CST3;ITIH2;TFPI;SERPIND1;A2M;APH1B;PSME2;VSIR;ABCA2;UCHL5;HRG;ITIH3;AHSG
prerank,actin binding (GO:0003779),0.36409345212925015,1.0721679941215125,0.36363636363636365,0.8226347444742715,1.0,35/170,13.17%,MICAL2;COBL;FXYD5;EZR;PHACTR1;PAWR;CALD1;GSN;PARVA;PDLIM7;SORBS1;GIPC1;ITGB1;FLNB;PRKCE;MLPH;ABL1;VCL;DMD;MRTFA;PDLIM5;DMTN;RDX;NCALD;MAP1B;TNNI3;MYOZ3;EMD;SYNE2;CAPZA1;MSRB2;ADD1;LIMA1;SSH3;PHACTR2
prerank,nucleotidyltransferase activity (GO:0016779),0.4884389572392354,1.0719250929656792,0.36935483870967745,0.8195872440517591,1.0,7/19,21.52%,PAPSS2;NUDT5;TUT7;TUT4;REV1;MOCS3;TENT2
prerank,ADP binding (GO:0043531),0.46632093881259373,1.0706366210670815,0.3628048780487805,0.8192706507588321,1.0,2/25,2.63%,ME1;GCLC
prerank,kinase binding (GO:0019900),0.3472806658052655,1.0703413043114438,0.3350202429149798,0.8164107565848501,1.0,70/434,13.57%,SLC12A7;EGFR;SLC12A2;TCF7L2;PKD1;ANK2;CCNA2;CIT;WNK1;PRKCD;FOXO3;UNC5C;GSN;SHC1;TAX1BP1;CNTLN;GSK3B;RHOBTB1;TTC28;AP2A2;SPRED2;NR4A3;ACSL3;TELO2;PTPN2;RNF138;DLG2;BECN1;DNAJC3;SKI;IRAK4;ESR1;STAT3;MAVS;PIP5K1A;PFKFB2;CDC25B;NBEA;DLG1;NSF;CHEK2;BCAR3;CDKN1B;IBTK;ATP1A4;AP2A1;RHOA;IQGAP1;RND3;TNNI3;AURKA;PLCG2;IRAK3;RB1CC1;LIMS1;PPP1R12A;CAB39;STRADA;SMCR8;PER1;RB1;TIAM1;CHP1;CARD16;TRIP6;FAM83H;NISCH;PAK2;PAX6;PRAM1
prerank,calcium:sodium antiporter activity (GO:0005432),0.5242265574939121,1.0693747113704875,0.4089285714285714,0.8153536543890119,1.0,1/10,0.69%,SLC24A3
prerank,GTPase binding (GO:0051020),0.35524946946107566,1.064398599598646,0.36627282491944146,0.8242654547127005,1.0,32/194,10.17%,PLCE1;CDC42EP5;EXOC4;NDRG1;AKAP13;SGSM2;ARHGDIB;YBX3;DOCK7;UNC13B;ERC1;MLPH;SRGAP2;PDE6D;HPS4;RAB11FIP3;BECN1;ANKRD27;RRAGB;RAPGEF6;OCRL;MYCBP2;RGP1;EXOC5;FGD6;RAB3GAP2;STRN3;PIH1D2;IQGAP1;RANBP2;EHD1;NCKAP1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4546838878490757,1.062900107385637,0.4076335877862595,0.8245497879908107,1.0,16/29,28.42%,ACER3;GANC;IDUA;NEU3;HPSE;GALC;GANAB;ENGASE;MGAM;HEXD;HYAL3;GAA;HPSE2;GBA2;NEU1;MOGS
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5097148970766805,1.0620978939804449,0.39593908629441626,0.8229340231173804,1.0,4/12,10.86%,PGF;ITGA5;VEGFA;ITGB3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.44003946570847746,-1.0596795285145315,0.38701298701298703,0.6989886643783801,1.0,8/13,15.60%,GABRG3;GABRA2;GLRA1;GABRA1;GLRA3;GABRG1;GABRA4;GABRA5
prerank,phosphatidylglycerol binding (GO:1901611),0.5008427606187877,1.059227765584992,0.4036850921273032,0.8266840929298797,1.0,2/13,2.58%,PITPNC1;PITPNA
prerank,MAP kinase activity (GO:0004707),-0.4280456897515985,-1.057932738964316,0.38345864661654133,0.6973199004887345,1.0,1/14,0.31%,MAPK4
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.47611835439565503,1.0535633595096447,0.3925373134328358,0.8373101658736732,1.0,8/20,23.86%,MAGI3;DLG2;DLG1;AK4;AK3;AK9;CASK;AK1
prerank,vitamin D receptor binding (GO:0042809),0.5076201081710017,1.0509544944160552,0.4316309719934102,0.8401667048220173,1.0,6/14,19.80%,RXRA;MED13;MED14;THRAP3;MED24;SNW1
prerank,N-acyltransferase activity (GO:0016410),-0.3465727367531772,-1.0463875090963857,0.36977491961414793,0.7194239822763776,1.0,5/32,12.05%,CERS4;TGM2;NMT2;CERS1;CERS2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4226448460282002,1.0431533947626273,0.40392706872370265,0.8561871132273999,1.0,5/37,8.80%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5108957985798842,1.0404347644174703,0.432520325203252,0.8594734113699048,1.0,4/12,20.30%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,sulfotransferase activity (GO:0008146),0.42797002591100575,1.0391415658780407,0.4301833568406206,0.85895458613726,1.0,5/33,4.55%,UST;HS3ST1;CHST13;CHST5;SULT1A1
prerank,store-operated calcium channel activity (GO:0015279),-0.47312669481227176,-1.0374660174302928,0.41232227488151657,0.734535933508271,1.0,6/10,14.87%,TRPC3;TRPC4;TRPC6;ORAI2;TRPC1;ORAI1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5165879854999985,1.0366981341079782,0.4452423698384201,0.8613110892739957,1.0,5/12,14.67%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.4896153710639678,1.036606296513122,0.43234323432343236,0.8579127149227889,1.0,3/15,2.80%,HS3ST4;HS3ST1;HS6ST2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.36644075159314543,-1.0366007859240343,0.37900874635568516,0.7304400147846343,1.0,6/25,12.02%,PARP14;ART3;PARP16;PARP8;TIPARP;PARP11
prerank,lipoprotein particle binding (GO:0071813),0.46669992476467403,1.0344641340641705,0.4366883116883117,0.8597930089191115,1.0,2/20,5.60%,THBS1;LDLR
prerank,"DNA binding, bending (GO:0008301)",0.4913997060757799,1.0306348987466614,0.4450084602368866,0.8657622563444082,1.0,3/14,8.68%,FOXD1;FOXL1;FOXC1
prerank,nuclear localization sequence binding (GO:0008139),0.461221963878731,1.029290494654748,0.43553459119496857,0.8654459343270143,1.0,5/18,15.97%,KPNA1;TNPO2;KPNA4;NUP153;NUP214
prerank,hexosyltransferase activity (GO:0016758),0.361056106282795,1.0290531370267058,0.4155844155844156,0.8625460346629018,1.0,23/101,20.30%,TMTC1;EXT1;MGAT4C;B3GNT2;LARGE1;HEXA;GCNT2;B4GALT1;POGLUT3;HAS1;PIGB;B4GAT1;A4GALT;B4GALNT3;LARGE2;POMGNT2;B3GNT9;ALG12;POGLUT2;POFUT1;CHPF2;B4GALT7;B3GNT6
prerank,cysteine-type peptidase activity (GO:0008234),0.38423321539437155,1.0271088936232913,0.42782834850455137,0.8639527001067612,1.0,25/73,20.81%,USP46;USP2;USP13;CAPN2;USP24;CASP6;USP34;USP49;USP15;USP25;USP1;USP10;USP7;OTUD7B;USP47;USP33;CASP2;USP28;USP9X;ATG4A;USP40;ATG4B;TINAGL1;USP21;USP36
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.36794766225304437,-1.0256439663642312,0.42480211081794195,0.7511207577401888,1.0,5/22,12.19%,APOE;PICALM;HSPG2;SYT1;HSP90B1
prerank,protein kinase regulator activity (GO:0019887),0.36668644419805385,1.022335277383679,0.4271604938271605,0.8718911003893344,1.0,16/95,11.55%,CCNA2;WNK1;WNT11;PARVA;FGF13;KIDINS220;DNAJC3;CCNL2;ELP3;MARK2;CDKN1B;CCNL1;CAB39;STRADA;SMCR8;CCNYL1
prerank,myosin binding (GO:0017022),0.39240573222565567,1.0189909620652011,0.45394736842105265,0.876874051573441,1.0,10/55,9.21%,CALD1;GSN;GIPC1;MLPH;RAB6A;DMD;NPHS1;SHROOM4;RHOA;RAB25
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.49823692523397123,1.01864900957484,0.4577114427860697,0.8741673332628677,1.0,3/12,3.62%,SHC1;GAB2;IRS1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5029845078021008,1.0165921610919404,0.4601328903654485,0.8756000214006742,1.0,9/11,32.25%,PRMT8;PRMT6;CARM1;NDUFAF7;PRMT5;FBXO11;PRMT2;PRMT9;PRMT3
prerank,PDZ domain binding (GO:0030165),0.38897293962116297,1.0162561826919132,0.44223107569721115,0.8729285700725379,1.0,11/61,8.00%,CRIM1;CIT;CXADR;FZD7;ERC1;SLC26A6;KIDINS220;ATP2B4;SNTG2;NSF;FZD1
prerank,NADP binding (GO:0050661),0.419639884291644,1.016084487459236,0.4524822695035461,0.8698693076301783,1.0,4/32,9.94%,ME1;GMDS;DECR1;LBR
prerank,phospholipase activity (GO:0004620),0.38158089954609437,1.0142751135673296,0.4619289340101523,0.8708326017869563,1.0,8/67,8.09%,PLCE1;MGLL;PLCB3;PNPLA3;PLA2G4F;PLA2G15;ABHD6;DDHD1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.43490288624793627,-1.0142644894126533,0.4694835680751174,0.7731813610459269,1.0,3/11,8.83%,LEF1;GATA2;MBD2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.45159831402565237,1.011737393886034,0.45718654434250766,0.8735680913391003,1.0,8/20,21.66%,PNPLA3;MOGAT3;PLA2G15;MOGAT1;LCLAT1;LPCAT1;GPAT3;ABHD5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34744416440066317,1.0102948667701608,0.46524663677130046,0.8736512522366676,1.0,29/147,11.72%,PLCE1;DOCK5;ARHGEF28;CYTH3;AKAP13;VAV2;DNMBP;RASGEF1B;BCR;RAP1A;HERC2;HPS4;ANKRD27;DENND2C;ARHGEF6;RAPGEF6;WDR41;MYCBP2;RGP1;FGD6;RAB3GAP2;DENND6A;ARHGEF10;SMCR8;ARHGEF5;GAPVD1;RANGRF;TIAM1;FARP1
prerank,galactosyltransferase activity (GO:0008378),0.5039994263543139,1.0090409383420564,0.48695652173913045,0.8729851212447579,1.0,6/11,20.30%,B4GALT1;B3GALT6;A4GALT;A3GALT2;B4GALT7;B3GNT6
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4697591633701296,1.0086858377915158,0.46314102564102566,0.8704154384800129,1.0,3/17,2.58%,PITPNC1;ATP10A;PITPNA
prerank,ubiquitin protein ligase activity (GO:0061630),0.3366710101854691,1.0068504885965506,0.47396386822529224,0.8716079816122051,1.0,52/228,16.80%,WWP1;NEDD4;TRAF3IP2;UBE4B;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;RNF114;TRIP12;CBLC;BIRC7;MYCBP2;RNF126;UBE2D3;LRSAM1;UBE4A;KCMF1;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF111;RNFT2;COP1;RNF122;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;RNF135;FANCL;ASB1;TRIM39;UBE2K;SH3RF3;NSMCE1;MKRN1;BFAR;UHRF2;RNF14;UBE3C
prerank,acylglycerol lipase activity (GO:0047372),0.5044108773994546,1.0067135186541207,0.45791245791245794,0.8684726689984484,1.0,2/11,6.80%,MGLL;ABHD6
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.3965144452211074,1.0064381444636488,0.46132971506105835,0.865842396525763,1.0,17/42,28.21%,CCNA2;CCNL2;CDKN1B;CCNL1;CCNYL1;CCND1;KAT2B;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNF;HEXIM1;CDKN2C;CCNE2;CCNT2
prerank,nuclease activity (GO:0004518),0.3894590040906833,1.0063603488496622,0.46965699208443273,0.8626180821595105,1.0,20/52,26.52%,N4BP2;STK31;EXO1;PLSCR1;ERCC5;WRN;APEX1;ZC3H12A;ERN2;RNASEH2A;DFFB;DIS3L2;RNASE6;REXO1;DDX1;RNASE3;EXOG;MAP1S;PARN;RNASE12
prerank,sequence-specific mRNA binding (GO:1990825),0.5112697717062787,1.0051088192998778,0.4592720970537262,0.8621689583221872,1.0,4/10,21.68%,ETF1;DHX9;FMR1;SSB
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4084981997122849,-1.001450303462426,0.45410628019323673,0.7991373337803107,1.0,5/12,25.23%,TBPL1;STAT1;RUVBL2;GTF2A1;RELA
prerank,zinc ion binding (GO:0008270),0.3277324987738109,1.0011033991996574,0.48900523560209425,0.8681370713177465,1.0,66/293,16.23%,ACER3;ZFPM2;TES;HDAC4;ADH7;KLF4;NPEPPS;HHIP;EEA1;KLF7;SEC24B;CLIP1;TAB3;ZFYVE1;PHEX;MMP16;SKI;ARIH1;MNAT1;TIMP2;ZMYND8;MBD1;PLA2G15;ADA;IDE;PLSCR1;CBLC;TNP2;MYCBP2;ZMYM2;MDM4;RXRA;ZNF8;P2RX4;GLI2;LIMS1;SEC23A;ZBTB32;ZDHHC15;TIMP1;ERAP1;ADAMTS3;SMPDL3A;MSRB2;ALKBH8;CZIB;USP33;CHORDC1;IFIH1;ARIH2;CHD3;UBA5;TK1;PITRM1;RNF2;ECE1;HDAC10;S100B;SEC24D;DPP3;KDM2A;ZDHHC20;NUDT12;DPEP1;CAD;SORD
prerank,Hsp90 protein binding (GO:0051879),0.4136954598768152,0.9991395475174231,0.47032640949554894,0.8694410795779148,1.0,7/33,12.34%,SLC12A2;TELO2;HDAC8;UNC45A;PPEF2;PPP5C;CHORDC1
prerank,kinase activator activity (GO:0019209),0.4208532897912593,0.9978746134870647,0.4744525547445255,0.8691242835981394,1.0,6/30,10.52%,WNK1;WNT11;FGF13;MARK2;CAB39;STRADA
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2922683310758666,-0.9977752185073973,0.4268292682926829,0.8014306968136244,1.0,20/56,20.36%,PIK3R1;NRG3;DOCK4;GRB14;CBLB;ANGPT2;SOCS5;FRS2;GAS6;BLNK;SHC3;DUSP3;SHC4;SH2B3;RACK1;ARHGEF16;FLT3LG;HYAL2;NRG1;ANGPT4
prerank,GDP binding (GO:0019003),0.37622089750142085,0.9967843470976534,0.47003994673768307,0.8685046075529327,1.0,24/63,28.40%,NRAS;KRAS;MRAS;RAP1A;ARL3;RAP2C;MIEF1;RIT1;RAB27B;RAB5B;RAB21;RHEB;RAN;RAB5A;RAB18;RAB11B;RAB35;RAB7A;RAB8A;RAB42;DIRAS2;RAP2B;RALB;RAB17
prerank,calcium-release channel activity (GO:0015278),-0.3864763312269983,-0.9955791356330708,0.456,0.8000164868682095,1.0,2/17,4.69%,ITPR1;RYR2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.43975102544218575,-0.9936900608363025,0.5034168564920274,0.7981139737646119,1.0,3/10,14.98%,CYBA;NCF2;NOX4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4424616767171835,0.9933924669973111,0.4748858447488584,0.8730559838392485,1.0,10/24,24.97%,IP6K2;PPIP5K2;IP6K1;IP6K3;AK4;AK3;AK9;PPIP5K1;AK1;NME6
prerank,ribosome binding (GO:0043022),0.3914406733573137,0.9924619969473638,0.4700139470013947,0.8719444793831761,1.0,11/46,17.64%,RPSA;ETF1;MRPS27;IGHMBP2;MTIF3;SERBP1;SEC61A1;EIF6;ZC3H12A;NAA15;EIF2S1
prerank,actinin binding (GO:0042805),0.44152781536855656,0.9915320974388604,0.45794392523364486,0.8708955095995298,1.0,6/21,9.88%,CACNA1C;CSRP3;PDLIM5;CSRP2;NFKB1;RARA
prerank,anion transmembrane transporter activity (GO:0008509),-0.4088677172953447,-0.9887304638394606,0.4610091743119266,0.8036680977150087,1.0,3/12,4.87%,SLCO2B1;SLC22A6;SLC39A8
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4236803860909258,0.9877285773051921,0.49025487256371814,0.8767245907571932,1.0,12/27,30.77%,POLR1A;POLR1F;POLR3K;PRIM1;POLR3F;POLR3A;POLR3B;CRCP;POLR1D;POLR1H;PRIMPOL;POLR1C
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.49527649356476244,0.987261393224194,0.5050505050505051,0.8745517397230848,1.0,4/11,18.11%,APEX2;APLF;APEX1;NEIL3
prerank,active ion transmembrane transporter activity (GO:0022853),0.403100001852182,0.9869095570392262,0.4791666666666667,0.8722075372140021,1.0,3/37,1.49%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,ubiquitin protein ligase binding (GO:0031625),0.32481593353197974,0.9866995843581448,0.5205479452054794,0.8694956376311039,1.0,52/254,17.25%,EGFR;SNCAIP;TANK;SMAD6;FHIT;USP2;USP13;MID1;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;SKI;ARIH1;CLU;IKBKE;CHEK2;GPI;NLK;HSPA1L;EGR2;USP25;JUN;SLC22A18;USP7;PER1;SMAD2;RB1;TRAF5;TNFRSF1B;CKB;XRCC5;TRIOBP;FATE1;CUL3;NPLOC4;CXCR4;PSMD1;FANCL;SPOP;CASC3;SQSTM1;PML;UBE2K;IKBKG;CUL1;AMBRA1;BCL10;PRKAR2A;TSG101
prerank,beta-tubulin binding (GO:0048487),-0.3277785018942516,-0.9866318799649554,0.4806451612903226,0.8021572913174656,1.0,9/31,18.69%,GJB6;TTLL7;EML4;PDCD5;GABARAPL1;GABARAP;TRPV4;PACRG;DLEC1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.39456333458266557,-0.9863626104211409,0.4795180722891566,0.7964167318508586,1.0,4/14,14.98%,MICAL1;CYBA;NCF2;NOX4
prerank,N-acetyltransferase activity (GO:0008080),0.4455685246673058,0.9855349136294647,0.49230769230769234,0.8690068369625968,1.0,9/19,26.46%,ATAT1;EP300;KAT2B;NAT1;SAT1;NAT10;ESCO1;NAA50;NAA80
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4576339015541479,0.984165522532968,0.4754653130287648,0.8690401010867136,1.0,4/15,13.00%,PIK3C2B;PI4KB;ATM;PIK3R3
prerank,cardiolipin binding (GO:1901612),-0.44147591155244803,-0.9823531058754429,0.5035128805620609,0.7995692124136512,1.0,2/10,12.82%,GSDMD;MME
prerank,methylation-dependent protein binding (GO:0140034),0.3765509022170189,0.9808805456981117,0.4864864864864865,0.8734922588156765,1.0,23/57,30.22%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;PYGO1;SUZ12;FMR1;MORC4;CHD1;ING1;THAP7;SPIN4;CBX2;ING3;NCAPD3;MPHOSPH8;CBX8;CHD8
prerank,single-stranded DNA binding (GO:0003697),0.3529215251386631,0.9808487488042327,0.49759615384615385,0.8703719538698316,1.0,28/93,20.73%,CRY2;RNF138;STN1;ERCC5;MCM7;MCM2;RAD23B;TOP1;BRCA2;IGHMBP2;NABP1;DDX11;RAD52;CDC45;DHX9;MCM9;RBBP8;RPA1;TOP3A;RAD51;ERCC1;NEIL3;DHX36;WDR48;RTF1;SWSAP1;SMC6;POLA1
prerank,hormone receptor binding (GO:0051427),0.4623025062285422,0.9780289620406287,0.4914196567862715,0.8736414783974786,1.0,3/14,17.78%,PTHLH;SOCS2;NCOA6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3268144632368175,0.9774254171896308,0.5318471337579618,0.8718001223560281,1.0,52/232,16.80%,WWP1;NEDD4;TRAF3IP2;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;RNF114;TRIP12;CBLC;BIRC7;MYCBP2;PIAS2;PIAS3;RNF126;UBE2D3;LRSAM1;EGR2;KCMF1;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF111;RNFT2;COP1;RNF122;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;RNF135;FANCL;ASB1;TRIM39;SH3RF3;NSMCE1;MKRN1;BFAR;UHRF2;RNF14;UBE3C
prerank,methylated histone binding (GO:0035064),0.37295532663036945,0.977118896160543,0.49805950840879687,0.8692920065971247,1.0,24/62,30.22%,TDRD3;ZMYND8;MBTD1;SGF29;CBX5;MORC3;BPTF;ZCWPW2;ATRX;PYGO1;SUZ12;FMR1;MORC4;CHD1;ING1;THAP7;SPIN4;CBX2;ING3;TAF1;NCAPD3;MPHOSPH8;CBX8;CHD8
prerank,four-way junction DNA binding (GO:0000400),0.45705123080867394,0.9745194357368886,0.5163398692810458,0.8718673358354674,1.0,5/17,20.60%,ABL1;WRN;YY1;FANCM;RAD51C
prerank,solute:proton symporter activity (GO:0015295),0.45541232020400996,0.9710554312741738,0.50814332247557,0.8765936339897933,1.0,1/16,1.19%,SLC2A13
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4025197612567809,0.9708212496756654,0.497907949790795,0.8739114547108233,1.0,6/32,11.00%,EGLN3;FTO;RIOX2;TMLHE;TYW5;JMJD4
prerank,phosphatidylinositol binding (GO:0035091),0.34992552727201603,0.9692190710895245,0.5387409200968523,0.8741643103394767,1.0,14/91,9.53%,TNFAIP8L3;ESYT3;PITPNC1;PITPNA;EEA1;SNX2;ESYT2;SNX24;BCAS3;ZFYVE1;ITPR2;PHF12;PARD3;FCHO2
prerank,thyroid hormone receptor binding (GO:0046966),0.415156249117549,0.9691506382770305,0.5128983308042488,0.8712725015376991,1.0,11/28,17.78%,JMJD1C;TRIP12;MED13;NCOR1;TRIP6;THRAP3;MED24;NSD1;BRD8;GAS2L1;NCOA6
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.40306518512052525,-0.9684905654302636,0.5012048192771085,0.8261240781092858,1.0,5/13,9.13%,PDGFD;PDGFRB;IL1R1;ERN1;PDGFRA
prerank,AMP binding (GO:0016208),0.4729111275182847,0.9678489133371452,0.49225473321858865,0.8710527638157705,1.0,2/11,6.38%,MPPED2;PFKP
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3875295078406248,0.9667850713193146,0.5090655509065551,0.8704105010997986,1.0,7/42,7.43%,BAIAP2L1;STXBP6;ANXA1;ANXA2;TMOD3;PDLIM5;EMB
prerank,protein homodimerization activity (GO:0042803),0.3135814861618301,0.9654806638769821,0.600802407221665,0.8702278364575502,1.0,114/589,17.25%,SLIT2;FOXP2;AOX1;EXT1;MAP3K5;ABCD3;LRP6;PDGFC;CAMK2D;MGLL;NECTIN3;ZBTB16;HES1;ABCG2;GRHL1;ADRB2;PRPS2;FGFR1;MID1;CPQ;BMPR1A;GLCE;SRGAP2;EEA1;NR4A3;MYOM3;SNX2;NPR3;ZBTB7B;HPS4;ACP3;RAB11FIP3;BHLHE40;PDCD6IP;NOG;PNPO;SPPL2A;PON3;STAT3;GDNF;DDIT3;CASR;RIPK2;XPNPEP1;IDE;MMACHC;CLTRN;JUP;NFS1;XPNPEP3;CHEK2;PDGFA;ERCC5;RABEP1;PAFAH1B2;TYW5;S100A10;PRMT8;CHUK;WRN;COMMD1;IRAK3;ACVR1;NRF1;VEGFA;HSPB8;SRM;NUDT5;CEP131;MVD;CISD2;SLC39A13;MKLN1;INHBB;SLC8B1;GLB1;CCDC66;ADD1;DGCR8;NAGA;NR6A1;ZDHHC2;FBXO4;TCF3;HNF4A;GALE;SH3GLB1;UBA5;ECE1;GSTM4;S100B;CEACAM5;ST3GAL2;ZBTB1;CARNMT1;ADAM10;PML;KYAT1;CEP43;TMEM192;SDCBP2;XDH;IKBKG;XPA;MAD2L1;KNSTRN;CEP57;SCARB2;STARD3NL;ABCD1;CREB3L3;PSMD7;BARD1;TSG101
prerank,GABA receptor activity (GO:0016917),0.43068839346863325,0.9649346988346286,0.5046875,0.8683728191983501,1.0,2/21,4.00%,GPR156;GABRA3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.39334138566781135,0.9642778053122908,0.5146853146853146,0.8668642885944288,1.0,7/38,8.84%,SORBS1;SHC1;GAB2;IRS1;NCK2;SHANK1;G3BP2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3160101058483,0.9637707910905954,0.5642633228840125,0.8648872897829615,1.0,53/269,17.25%,EGFR;SNCAIP;TANK;SMAD6;FHIT;USP2;USP13;MID1;GSK3B;HERC2;VCP;UBE2B;VCL;BECN1;SKI;ARIH1;CLU;IKBKE;CHEK2;GPI;NLK;HSPA1L;EGR2;USP25;JUN;SLC22A18;USP7;PER1;SMAD2;RB1;TRAF5;TNFRSF1B;DDRGK1;CKB;XRCC5;TRIOBP;FATE1;CUL3;NPLOC4;CXCR4;PSMD1;FANCL;SPOP;CASC3;SQSTM1;PML;UBE2K;IKBKG;CUL1;AMBRA1;BCL10;PRKAR2A;TSG101
prerank,ligand-gated cation channel activity (GO:0099094),0.35490819388812767,0.9625868659684209,0.5240506329113924,0.8644626884985632,1.0,7/75,8.65%,KCNJ2;PTK2B;KCNJ15;TRPM4;P2RX2;GRIK4;P2RX4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.406000932381019,-0.9617025999150264,0.5322195704057279,0.8366812454035399,1.0,2/11,13.25%,HCN1;HCN2
prerank,kinase activity (GO:0016301),0.3399690823342258,0.9614488229172593,0.5373831775700935,0.8639984207778406,1.0,21/109,13.42%,STK39;GSK3B;PAPSS2;ABL1;PIK3C2B;IP6K2;RFK;ETNK1;TRRAP;DGKA;SHPK;PI4KB;HYKK;CCL3;NADK;MTOR;PPIP5K2;CHKB;CKB;PKN2;AGK
prerank,acyl-CoA hydrolase activity (GO:0047617),0.440545241044688,0.9592337389345317,0.506578947368421,0.8656703733590289,1.0,6/17,19.01%,ACOT8;ACOT12;ACOT9;ACOT13;ABCD1;ACOT11
prerank,transferrin receptor binding (GO:1990459),0.47921229111036057,0.9546650932258548,0.5195246179966044,0.8726892512182626,1.0,6/10,26.45%,SNX2;CHUK;IKBKG;SNX4;HFE;IKBKB
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31176743596503154,0.9539084952417483,0.5905834186284544,0.8713584881336731,1.0,97/346,22.08%,WWP1;NEDD4;TRAF3IP2;FBXO10;WWP2;RNF144A;RNF115;HERC2;RNF138;RNF185;UBR4;FBXW8;UBE2B;ARIH1;MKRN3;UBR5;RNF19A;TRIM44;BIRC6;RNF114;TRIP12;CBLC;BIRC7;RNF214;MYCBP2;RNF141;TRIM47;KLHL13;RNF126;UBE2D3;LRSAM1;FBXW11;KCMF1;FBXL6;TRIM41;TRIM7;TRIM26;TRIM55;FBXO17;RNF146;RNF111;UBE2Z;TRAF5;RNFT2;COP1;RNF122;FBXO4;RNF168;ARIH2;ANKIB1;SMURF1;CUL3;RNF2;ERCC8;UBE2S;RNF135;FANCL;ASB1;TRIM39;PML;UBE2K;SH3RF3;NSMCE1;CHFR;MKRN1;BFAR;CUL1;UHRF2;RNF14;UBE3C;BARD1;MKRN2;DTX3;FBXO25;BIRC3;TRIM25;TRAF3;TRIM45;TSPAN17;TRIM35;UBE2N;UBE2W;RNF123;RNF31;CNOT4;MIB1;NFX1;RNF8;HUWE1;RNF130;PPIL2;UBE2M;CDC42;RBCK1;CUL4A;RMND5A;ANAPC11
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.35891839794904545,-0.9537851695551813,0.515625,0.8495525928982182,1.0,4/18,12.92%,PIK3R1;PIK3R6;SOCS5;PIK3R5
prerank,water transmembrane transporter activity (GO:0005372),-0.41479718234785223,-0.9537153744556827,0.5036144578313253,0.8432465907317036,1.0,2/11,7.73%,AQP11;AQP4
prerank,ion gated channel activity (GO:0022839),-0.33886652033553055,-0.9533667943332559,0.5222551928783383,0.8376832353030812,1.0,9/24,15.56%,KCNT2;ANO4;TTYH2;KCNT1;ANO2;TTYH1;TMEM63B;TMEM63A;ANO3
prerank,voltage-gated calcium channel activity (GO:0005245),0.38728026893296047,0.9515225455350317,0.5127840909090909,0.8735975661464628,1.0,7/37,7.26%,CACNA1C;CACHD1;CACNA1G;TMC1;ITGAV;CACNG6;CACNA1F
prerank,platelet-derived growth factor binding (GO:0048407),0.47824851502706267,0.9511405019064837,0.5347222222222222,0.871578355938551,1.0,3/11,7.95%,COL6A1;COL3A1;PDGFA
prerank,adenylyltransferase activity (GO:0070566),0.42159340011070046,0.9510752759346406,0.5045871559633027,0.8687729388475736,1.0,3/21,8.12%,NMNAT2;ABL1;NMNAT1
prerank,nuclear export signal receptor activity (GO:0005049),0.47190531365386,0.9501526200489777,0.5252525252525253,0.8678164088768124,1.0,5/11,24.28%,XPO1;NUP214;XPO4;RAN;XPO7
prerank,protein kinase inhibitor activity (GO:0004860),0.3879899048380906,0.9498509034017251,0.5144508670520231,0.8656642126508864,1.0,7/42,10.90%,CIT;PARVA;SPRED2;DNAJC3;CDKN1B;IBTK;SMCR8
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4124703317435647,0.9492412022701241,0.5412844036697247,0.8640049500689707,1.0,10/27,26.92%,POLR1A;POLR1F;POLR3K;POLR3F;POLR3A;TENT2;POLR3B;CRCP;POLR1D;POLR1H
prerank,actin monomer binding (GO:0003785),0.4114574524317235,0.9465032340892705,0.5241691842900302,0.8671810746705187,1.0,4/22,5.74%,COBL;PRKCE;ABL1;MRTFA
prerank,protein kinase C activity (GO:0004697),-0.3848710183565829,-0.9447215588307134,0.5047846889952153,0.852225770594774,1.0,5/14,7.50%,PRKCH;PRKD1;PRKCB;PRKCQ;PRKCZ
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4505021640680889,0.9445908481113291,0.5387149917627677,0.8681063585064391,1.0,2/13,12.66%,EXO1;SLX4
prerank,kinase inhibitor activity (GO:0019210),0.39308930199315406,0.9445446112114868,0.5094066570188133,0.8653000044998106,1.0,5/33,10.90%,LRP6;PARVA;DNAJC3;CDKN1B;SMCR8
prerank,cytokine receptor activity (GO:0004896),0.34040338649466595,0.9428367777146949,0.5533498759305211,0.8659094430121413,1.0,7/83,6.25%,F3;IL17RE;IL22RA1;CD44;CMKLR1;IL17RA;IL17RD
prerank,aminopeptidase activity (GO:0004177),0.4051102657157071,0.9407487466656408,0.5303951367781155,0.8672733570054826,1.0,8/26,17.76%,NPEPPS;MMP16;XPNPEP1;XPNPEP3;MMP14;ERAP1;LAP3;METAP1D
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4477243118192601,0.9399435599389641,0.5326633165829145,0.8661173335812539,1.0,7/13,30.94%,TRMT10A;TARBP1;METTL1;TRMT1L;TRMT11;THUMPD2;FTSJ1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.37257624733081074,-0.9398491894238931,0.5308988764044944,0.857290817117897,1.0,4/15,12.71%,EPB41;PICALM;SNAP91;SCARB1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.46238796725879494,0.9387923986334689,0.5202108963093146,0.8656382943382978,1.0,3/10,13.00%,PIK3C2B;ATM;PIK3R3
prerank,exoribonuclease activity (GO:0004532),0.45585969192571896,0.9373074508152685,0.538971807628524,0.8659972740281384,1.0,7/12,32.48%,EXOSC7;ZC3H12A;CNOT7;EXOSC1;EXOSC4;EXOSC2;EXOSC3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3955427646535168,0.9341804855866931,0.5432835820895522,0.8693985924192974,1.0,15/28,35.69%,EXO1;APEX1;RPP38;RNASEH2A;AGO2;DROSHA;DBR1;EDC3;ELAC1;NUDT16L1;AGO3;DICER1;ELAC2;RNASEH1;POP1
prerank,cGMP binding (GO:0030553),0.45672552397661514,0.9323007034324031,0.5202020202020202,0.8703860207195232,1.0,2/11,5.63%,PDE5A;PDE10A
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2644591921112826,-0.9299126589276608,0.5634517766497462,0.8748587675842117,1.0,21/74,19.98%,NADK2;DGKB;DGKI;GK;DGKD;PIK3C2A;PANK1;SPHK1;DGKG;HK2;PGM2L1;FAM20C;PAPSS1;CHKA;IDNK;IPMK;IPPK;DGKE;PIK3CG;DGKZ;SPHK2
prerank,epidermal growth factor receptor binding (GO:0005154),0.3957388670614588,0.9294944651452235,0.541033434650456,0.8732930011166318,1.0,8/25,10.77%,SHC1;EFEMP1;SNX2;PLSCR1;AGR2;CBLC;ARF4;ATXN2
prerank,RNA binding (GO:0003723),0.2965501800722314,0.9291799795824712,0.7767767767767768,0.8711237917177671,1.0,350/1321,22.84%,STRBP;MSI2;RNMT;SLTM;MBNL1;SAMD4A;SPATS2L;TES;FNDC3A;DDX5;EZR;RBFOX2;RPSA;AHNAK;EIF4G3;ANXA2;ZCCHC24;DSP;GPATCH8;PURG;HOXB6;TCF20;CTNNA1;YBX3;RBM47;FLNB;LARP1B;GOLGB1;POLR1G;CAST;TDRD3;ERI3;DIAPH1;HDLBP;BMS1;SREK1;LUC7L2;SMG6;SON;EIF4G1;PNISR;VCP;DDX17;SIDT2;NUFIP2;ANKHD1;ALG13;RBM6;SNTB2;SRSF11;PRR3;FNDC3B;ZC3H7A;MKRN3;THOC2;STAT3;DUSP14;SRSF5;KDM1A;C1D;LRP1;CEBPZ;KMT2C;SRRM2;EWSR1;ZFR;FASTKD1;ZCCHC7;SRSF6;FAM120C;SYNCRIP;BZW1;NUDT4;SLPI;HNRNPH1;CELF1;CELF3;MOV10;RDX;MBNL2;YARS1;SCAF8;DXO;KTN1;MARK2;KIF1C;RBM39;FUS;ZC3H14;PABPC4;LARP4B;RBM27;ZC3H18;DDX18;CCDC9;DDX19B;TYW5;DUSP11;WDR43;G3BP2;RBM25;L1TD1;BCLAF1;ETF1;EBNA1BP2;DDX43;ELP5;PCBP4;RBMX;LBR;MTO1;TOP1;U2AF2;JUN;MRPS27;MTDH;GSPT1;USP10;APEX1;NUDT5;RBM33;CS;PRRC2C;ATXN2;IGHMBP2;TCERG1;CISD2;SERBP1;RBM28;KRT18;RPP38;DDX11;PLEC;ZBED4;MRPL32;MRPL14;EIF3E;MRPL40;PABPC1;EXOSC7;RBMS3;DDX42;SMC1A;ZCCHC8;ALKBH8;UTP6;ADD1;AATF;CKAP4;TDRD9;ARCN1;DGCR8;EIF3A;NCOA5;CPNE3;NOP56;ZC3H12A;SNRNP70;SCAF11;RRBP1;IFIH1;TRIP6;BRIX1;NELFE;ABCF1;SRRM1;PPRC1;GTPBP4;RPF1;SMG1;FARSA;MRPS31;PKN2;PRKDC;XRCC5;CSNK1E;CHD3;PUM2;ANXA7;TDRD7;ZC3H12D;NIP7;EIF2AK4;RBM34;PUS10;DHX9;STAU1;TUT7;DHX57;FYTTD1;PRPF3;GPKOW;RPUSD4;CDK11B;HNRNPM;TLR8;DCP1A;CASC3;BAZ2A;PUM1;U2SURP;KIN;TRMT10A;SCAF4;CHTOP;SF3B1;SF3B2;PDCD11;PPIG;EIF2S2;THRAP3;NOA1;NOL11;SEC23IP;AGO2;DDX21;DDX56;DDX49;SEC63;MKRN1;JMJD6;MRPL21;MEX3A;PRPF38B;ANKRD17;NAA15;MRPL42;TUT4;YY1;CDK13;ANXA11;NQO1;MRPS30;SRPK1;PSMC1;BARD1;YLPM1;PDAP1;ZC3H12C;MTIF2;WDR3;MKRN2;DIDO1;RBM14;EXOSC1;UTP4;MTHFSD;EIF2S1;ZC3H15;PUM3;DROSHA;KHDRBS1;DHX36;TRAP1;ZC3H11A;LSM8;DALRD3;KRI1;LSM2;FDPS;SNRNP35;CIRBP;EIF4B;WBP4;THOC5;RRP1B;TASOR;FXR2;USO1;KCTD12;MRPS28;MRPS35;LSM14B;SNRNP40;TRIM25;PNLDC1;ESF1;LARP4;RTF1;PCDHGA9;GANAB;NXF1;SRSF2;UBE2N;MATR3;CAPRIN1;DAZAP1;SEPSECS;HELB;SNW1;RAN;URB1;PNN;FMR1;IMMT;CNOT4;EIF4G2;FAM133B;MYEF2;TRA2B;ERH;ILF2;USP36;FBRSL1;NFX1;NUP98;PCDH20;YTHDF2;EPRS1;HUWE1;BYSL;DCAF13;HMGN2;DDX1;DBR1;LGALS3;NKAP;ALKBH5;NUDT1;MAZ;NOL3;MCAT;RBM3;SSB;SRPRA;LLPH;NOP58;UBAP2L;R3HDM2;SRSF12;STXBP1;LACTB2;NAF1;FLNA;NANOS2;ZCRB1;WDR75;UTP11;FASTKD5;TRMT1L;KNOP1;PRPF40B;FAM32A;TNRC6A;NCBP3;RBM5;FTSJ3;SRRT;NOC3L;FIP1L1
prerank,P-type ion transporter activity (GO:0015662),0.46964466861840726,0.9280904678260412,0.5692567567567568,0.8704828527098604,1.0,2/12,5.13%,ATP2C2;ATP2B4
prerank,lipase activator activity (GO:0060229),-0.4094886492374348,-0.925355944786093,0.5658198614318707,0.8788546863599613,1.0,6/10,31.54%,ARHGAP6;BTK;CCL5;SRC;APOH;CCL8
prerank,phosphatase activity (GO:0016791),0.34316799091874395,0.9252397403083811,0.5648854961832062,0.8732334008457369,1.0,15/73,14.97%,PLPPR2;PLPP3;ALPL;ACP3;NANP;OCRL;DUSP16;DUSP11;DUSP5;LPIN2;DUSP10;PPP5C;PLPP1;SBF1;ACP4
prerank,pyridoxal phosphate binding (GO:0030170),0.41450314347161377,0.9248659113526823,0.5383386581469649,0.8711834538711535,1.0,2/20,5.65%,PYGB;PNPO
prerank,voltage-gated chloride channel activity (GO:0005247),0.46833372051709243,0.9245047424162828,0.5524126455906821,0.8691857366205448,1.0,2/10,12.25%,ANO6;CLCN5
prerank,growth factor receptor binding (GO:0070851),0.32777417131674297,0.9242632986173537,0.5778045838359469,0.866962865089744,1.0,20/95,13.31%,PGF;PDGFC;SHC1;FGF2;EFEMP1;SNX2;ITGA5;PLSCR1;AGR2;IL10;CBLC;PDGFA;VEGFA;ARF4;ATXN2;ITGB3;ERAP1;FGF22;TRIP6;PIBF1
prerank,hydro-lyase activity (GO:0016836),0.37594122435870697,0.9238967509364208,0.5663956639566395,0.8649261212611479,1.0,7/41,11.32%,EHHADH;GMDS;AUH;CYP2S1;ECHDC1;UROC1;TGDS
prerank,syntaxin-1 binding (GO:0017075),-0.3418106183935172,-0.922186423364323,0.5757575757575758,0.8795378189301417,1.0,4/22,10.47%,UNC13C;SNAP25;SYT1;SYP
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4147893504628651,0.9211789962167594,0.5522151898734177,0.8675052298738604,1.0,2/19,1.79%,EFNA5;ABI1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.36075832594301815,0.9206757481119348,0.5613333333333334,0.8657506127116985,1.0,14/49,16.37%,TAB3;VCP;IKBKE;RAD23B;OTUD7B;WDR81;UIMC1;ZRANB1;RNF168;TNIP1;ZBTB1;SQSTM1;ZFAND6;IKBKG
prerank,chemokine binding (GO:0019956),0.3763613513517943,0.9203622605998796,0.5560407569141194,0.8636145136696806,1.0,5/30,14.55%,ITGB1;FGF2;ITGAV;ITGB3;CXCR4
prerank,histone demethylase activity (GO:0032452),0.3939049385421773,0.9199047034369242,0.5710102489019033,0.8618156071916265,1.0,9/27,18.21%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;JMJD6;HR;FBXL19
prerank,endonuclease activity (GO:0004519),0.3544643051232902,0.9191466147176236,0.5663956639566395,0.8607055975058245,1.0,14/49,23.22%,N4BP2;SMG6;ERCC5;APLF;APEX1;ZC3H12A;ERN2;ZC3H12D;AGO2;ZC3H12C;LACTB2;MBD4;EXOG;YBEY
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4533086386752545,0.9173297875375304,0.5415224913494809,0.8616165890340097,1.0,4/10,20.11%,B4GALT1;B3GALT6;A3GALT2;B4GALT7
prerank,GTPase activity (GO:0003924),0.3067755774559878,0.91691811668961,0.6353829557713053,0.8597642557222034,1.0,26/192,13.24%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;RAB43;BMS1;RAP1A;RAB6A;ATL2;RHOQ;GNL1;GNG8;RRAGB;RAP2C;RHOA;RND3;GNA13;GSPT1;RIT1;GTPBP4;GPN1;GFM2;ENTPD7
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3124149276945289,-0.9163877408579394,0.585635359116022,0.8864823371083482,1.0,3/27,2.90%,APOE;PICALM;HSPG2
prerank,protein heterodimerization activity (GO:0046982),0.3090044420996942,0.9154088703826525,0.6405228758169934,0.8601689369215131,1.0,29/178,12.33%,KCNB2;EXT1;ADRA1B;ATP1B1;KCNB1;ITGB1;BMP6;HEXA;MEF2A;AGTR1;NR4A2;SNX2;PAFAH1B1;BHLHE40;DDIT3;PDGFA;TLR4;SAE1;PAFAH1B2;ATP1A1;CHUK;AURKA;IRAK3;KATNB1;ATF6;ERBB2;SMC1A;ADD1;NR4A1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.3267638306445605,-0.9119061693244108,0.6277602523659306,0.890929656542952,1.0,7/22,21.83%,CPEB2;HNRNPA0;ELAVL4;EXOSC9;CPEB3;RBM24;ELAVL3
prerank,protein kinase activator activity (GO:0030295),0.34185862755895857,0.9112976934296577,0.586436170212766,0.8656106396799352,1.0,10/60,10.52%,ABI1;WNK1;WNT11;FGF13;FAM20A;MARK2;IQGAP1;MLST8;CAB39;STRADA
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3803385272799914,0.9109786408214359,0.5765379113018598,0.8635553227877749,1.0,13/33,20.27%,RNF144A;RNF185;ARIH1;RNF19A;ZMYM2;DCUN1D5;TCERG1;ARIH2;ANKIB1;RNF14;DCUN1D4;DCUN1D2;DCUN1D1
prerank,microtubule binding (GO:0008017),0.30386575270223953,0.9097552534141663,0.6705882352941176,0.8634206432990444,1.0,49/222,18.07%,EZR;NDRG1;CLIP4;MAPRE2;RP1;KIF13A;MTUS1;MID1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;KIF1B;PAFAH1B1;ARL3;GAS2L2;KIF1C;TOGARAM1;KIF9;CAPN6;DYNC1I1;MAP1B;MACO1;FBXW11;KIF7;KATNB1;KIF16B;MAST2;CCDC66;CHP1;TUBGCP6;RMDN3;POLB;KRIT1;RMDN1;TUBGCP5;CEP44;HOOK3;KIF3B;KNSTRN;CEP57;FAM161A;TUBGCP4;EML6;MAP6;GAS2L1;WHAMM
prerank,phospholipase activator activity (GO:0016004),-0.40825338926453514,-0.9096746977474869,0.5707547169811321,0.8896480053637278,1.0,6/10,31.54%,ARHGAP6;BTK;CCL5;SRC;STX4;CCL8
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3381852211017199,-0.9096087363120942,0.5821727019498607,0.8834316445674425,1.0,7/20,17.41%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.446956900681972,0.9093361648151544,0.5584192439862543,0.8616253942090362,1.0,5/11,27.91%,NUDT4;NUDT5;NUDT1;NUDT7;NUDT16L1
prerank,DNA replication origin binding (GO:0003688),0.40275090843388506,0.9042368353967277,0.5588697017268446,0.8689182186208563,1.0,6/23,15.17%,MCM7;MCM2;DDX11;CDC45;DHX9;MCM9
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.40750501874563927,-0.9040556302036256,0.5970149253731343,0.8905232939709999,1.0,2/10,7.27%,KDM7A;KDM2B
prerank,nucleotide diphosphatase activity (GO:0004551),0.4221964629249627,0.9027544515865158,0.5863787375415282,0.8693190075970777,1.0,4/14,15.84%,FHIT;NUDT4;NUDT17;NUDT12
prerank,nuclear receptor coactivator activity (GO:0030374),-0.26780018539186184,-0.9011758016389445,0.6455696202531646,0.8908204768747846,1.0,12/52,15.93%,TACC1;NCOA1;PPARGC1B;ETS1;PRKCB;PPARGC1A;ELK1;ACTN4;PKN1;CNOT9;MED1;NCOA7
prerank,cytokine receptor binding (GO:0005126),-0.24927976565481094,-0.899638509883787,0.6683673469387755,0.8881932804410176,1.0,14/83,13.42%,IL34;TGFBR3;CXCL12;CSF1;IL13RA1;IL6R;OSMR;SPRED1;IL18;IL6ST;SDCBP;MIF;LIFR;CCL19
prerank,death domain binding (GO:0070513),0.43697767082815375,0.8989109653916232,0.5780141843971631,0.8736891474732056,1.0,2/11,3.12%,CRADD;DAPL1
prerank,nuclear import signal receptor activity (GO:0061608),0.41891204283082123,0.898380298966931,0.5644067796610169,0.8719279035067382,1.0,5/15,25.35%,KPNA1;TNPO2;KPNA4;TNPO3;IPO4
prerank,C-C chemokine receptor activity (GO:0016493),-0.326068239452022,-0.8963868322461828,0.5896739130434783,0.8896676569526165,1.0,1/21,1.80%,CCR9
prerank,amino acid binding (GO:0016597),-0.3060062564600047,-0.8962820410135725,0.6319218241042345,0.8837797748887531,1.0,10/31,15.85%,GRM7;NOS3;GRIN2B;GRIN1;GLRA1;GLRA3;ASS1;GRIN3A;AGXT;DDAH2
prerank,carboxypeptidase activity (GO:0004180),-0.28542513945727316,-0.8955199196930884,0.6382252559726962,0.8794214836454194,1.0,5/35,10.06%,AEBP1;AGBL4;CTSA;CTSZ;ACE2
prerank,guanyl ribonucleotide binding (GO:0032561),0.29594669016522673,0.8950808591127952,0.6745945945945946,0.8753641334312809,1.0,24/196,11.50%,RHOJ;MPPED2;ATL3;PDE5A;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAP1A;RAB6A;ATL2;PDE10A;ARL3;RHOQ;GNL1;ARF3;RRAGB;RAP2C;RHOA;RND3;ARF4;ARHGEF5;MIEF1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3701826236711701,0.8940106864935433,0.5968882602545968,0.8746377768213132,1.0,4/35,4.64%,PLCE1;MPPED2;PLCB3;APEX2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3165607092453045,0.8938522102896003,0.6300236406619385,0.8723257309986217,1.0,34/100,22.68%,CYTH3;ARAP1;PLEKHA4;GAB2;PLCZ1;WIPI2;SNX24;ZFYVE1;ARAP2;RLBP1;GOLPH3;GBF1;IQGAP1;PARD3;COMMD1;KIF16B;SNX12;FCHSD2;DAPP1;ARFIP1;ARFIP2;ANXA8;SNX20;ATG2A;SNX13;ZFYVE19;OSBPL5;WDR45B;PLA2G4A;RUBCN;PLEKHF1;FERMT2;ZFYVE26;MYO10
prerank,glycine binding (GO:0016594),-0.3921905230461773,-0.8917285669536815,0.6285046728971962,0.8822254034121282,1.0,5/11,14.15%,GRIN2B;GRIN1;GLRA1;GLRA3;GRIN3A
prerank,C-C chemokine binding (GO:0019957),-0.3220704357037728,-0.8910232205322739,0.6149425287356322,0.8777659533778661,1.0,1/22,1.80%,CCR9
prerank,exonuclease activity (GO:0004527),0.34525882237326705,0.8904178297764918,0.6136986301369863,0.8760967329521325,1.0,15/46,22.86%,REV3L;APEX2;EXO1;DXO;WRN;APLF;APEX1;EXOSC7;ZC3H12A;CNOT7;EXOSC1;REXO1;EXD2;RAD50;EXOG
prerank,LRR domain binding (GO:0030275),0.4175986651709176,0.8894226487923335,0.5882352941176471,0.8754416564121769,1.0,6/14,14.16%,PAWR;ERC1;MRTFA;DDIT3;AATF;ZXDC
prerank,phosphatase inhibitor activity (GO:0019212),0.39603382093353245,0.8869956542454737,0.6021341463414634,0.877413977891336,1.0,9/20,25.43%,CABIN1;STYXL1;BOD1L1;URI1;MGAT5;ARPP19;LGALS3;STYX;PPME1
prerank,transcription coregulator binding (GO:0001221),0.3444299146602286,0.8857237373757837,0.6114130434782609,0.8772826494034562,1.0,14/50,18.96%,CIT;ZBTB16;ESR1;LCOR;EHMT1;RORA;PER3;PER1;EED;SUZ12;ZBTB7A;EHMT2;PER2;NEK6
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.35306279938661633,0.883630211479643,0.6134453781512605,0.8783897530308863,1.0,15/38,22.64%,PLEKHA4;PLCZ1;WIPI2;ZFYVE1;PARD3;KIF16B;SNX12;SNX20;ATG2A;SNX13;ZFYVE19;WDR45B;PLA2G4A;PLEKHF1;ZFYVE26
prerank,deoxyribonuclease activity (GO:0004536),0.4285717960713655,0.8765573253779317,0.6156405990016639,0.8885831721243078,1.0,6/14,26.18%,ERCC5;APLF;APEX1;DFFB;MBD4;MAP1S
prerank,metallocarboxypeptidase activity (GO:0004181),-0.302145910050593,-0.8756655242678915,0.6617647058823529,0.9056430886132528,1.0,2/26,2.55%,AEBP1;AGBL4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3564800307632923,0.8740079469184844,0.6414285714285715,0.8905031825703676,1.0,19/34,32.48%,ERI3;PAN3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;CNOT1;DIS3;EXOSC3
prerank,MHC class II protein complex binding (GO:0023026),0.43098040144834393,0.8735059386865309,0.6221033868092691,0.8888571044639069,1.0,1/11,1.55%,ATP1B1
prerank,lipase activity (GO:0016298),0.34910665000632507,0.8731251041019885,0.6432506887052342,0.8869788900959076,1.0,11/43,19.51%,MGLL;PNPLA3;PLA2G15;ABHD6;DAGLB;DDHD1;LCAT;PITPNM3;SEC23IP;LDAH;ABHD2
prerank,ferrous iron binding (GO:0008198),0.3924191028528182,0.8722149649711084,0.6220839813374806,0.8859594259300092,1.0,2/21,4.65%,EGLN3;FTO
prerank,nucleoside-triphosphatase activity (GO:0017111),0.28851736836493785,0.871044289819476,0.7502634351949421,0.8854887055167022,1.0,37/248,14.40%,RHOJ;ARHGDIB;ATL3;NRAS;KRAS;MRAS;RHOBTB1;RAB43;BMS1;RAP1A;RAB6A;ATL2;VCP;RHOQ;CLU;GNL1;GNG8;RRAGB;RAP2C;KIF1C;CHD1L;KLC1;VWA8;DYNC1I1;RHOA;RND3;GNA13;GSPT1;TDRD9;RIT1;GTPBP4;GPN1;GFM2;ENTPD7;CHD3;RAB24;DHX9
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.41360861953301353,0.8704808284480433,0.6210873146622735,0.8839203267661551,1.0,6/15,31.51%,KMT2C;KMT2D;WDR82;KMT2A;SETD1B;ASH2L
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.37027432675218575,0.8697305940581345,0.6041055718475073,0.8827502686965013,1.0,11/27,20.27%,RNF144A;ARIH1;RNF19A;ZMYM2;DCUN1D5;ARIH2;ANKIB1;RNF14;DCUN1D4;DCUN1D2;DCUN1D1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.43126543259859507,0.8654933477205069,0.631578947368421,0.887577844187806,1.0,3/11,22.07%,SLC25A25;SLC19A1;SLC25A17
prerank,metalloexopeptidase activity (GO:0008235),0.3352037114164817,0.865127025432217,0.6407506702412868,0.8857119191847136,1.0,14/51,15.90%,NPEPPS;CPQ;MMP16;XPNPEP1;CPA5;XPNPEP3;CPA4;CPA3;MMP14;AGBL3;ERAP1;LAP3;CPB1;DPEP1
prerank,phosphatidic acid binding (GO:0070300),0.3922337355630881,0.8635716540477173,0.6495176848874598,0.8858159128603459,1.0,4/19,9.74%,MARK1;PITPNC1;RAPGEF6;COMMD1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3920985237655785,-0.8610132058161573,0.6591422121896162,0.9310561171139771,1.0,5/10,18.18%,CASP4;CFLAR;CASP3;CASP1;CASP12
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.42459322648189846,0.8608252371366752,0.6094771241830066,0.8881034531624574,1.0,5/11,27.51%,NAA40;NAA15;NAA50;NAA80;NAA60
prerank,ephrin receptor binding (GO:0046875),0.3830690642325226,0.8598635534316103,0.6352201257861635,0.8873655558568174,1.0,3/21,3.61%,EFNA5;SHC1;ABL1
prerank,miRNA binding (GO:0035198),0.36078547784148307,0.8591605879618132,0.6304985337243402,0.886124378608067,1.0,11/30,22.92%,ZC3H7A;ZC3H12A;PUM2;TUT7;PUM1;AGO2;DDX21;TUT4;MATR3;FMR1;RBM4
prerank,semaphorin receptor binding (GO:0030215),0.3801854535030636,0.8579502340353585,0.6477794793261868,0.8856737695664378,1.0,3/23,2.43%,SEMA3E;SEMA3D;SEMA3C
prerank,motor activity (GO:0003774),-0.24976066011024686,-0.8574788860110426,0.7875,0.932118848915786,1.0,14/60,15.18%,STARD9;MYO6;MYH9;KIF3C;KIF6;KIFC3;MYL6;KIF26A;KIF26B;KIF1A;KIF5C;KIF21B;DYNLRB1;GPR88
prerank,cAMP response element binding (GO:0035497),0.44274962982362576,0.8569785893034915,0.6395759717314488,0.8847037902422218,1.0,5/10,15.01%,NR4A3;ATF7;JUN;CREB3L1;ATF2
prerank,phospholipase A2 activity (GO:0004623),0.3728609907189168,0.8561177337335696,0.6570121951219512,0.8836443435119044,1.0,3/26,6.16%,PNPLA3;PLA2G4F;PLA2G15
prerank,translation elongation factor activity (GO:0003746),-0.3516999721426703,-0.8546318005600295,0.6666666666666666,0.9317627777449118,1.0,2/14,5.70%,EEF1A1;EEF1B2
prerank,SH2 domain binding (GO:0042169),0.35192484765477183,0.8544721605528598,0.6393210749646393,0.8839900573302599,1.0,6/31,9.16%,ABL1;IRS1;NLK;RUFY1;ARHGAP5;AFAP1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3247061294021199,0.8542620815051186,0.6921086675291074,0.8819548564668676,1.0,11/60,13.19%,PPP3CA;PPP1R3C;PPM1H;PPTC7;PHLPP2;CDC14A;PPEF2;CDKN3;PPP5C;ILKAP;PPM1A
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.26936744371017707,-0.8532372647285954,0.7566539923954373,0.9286928961082498,1.0,6/49,10.61%,ATP1A2;ENPP6;SAMHD1;PXYLP1;DUSP23;PTPRO
prerank,steroid hydroxylase activity (GO:0008395),0.39533564429004586,0.8528298298373219,0.6380471380471381,0.8820951793499501,1.0,2/16,5.06%,CYP1B1;CYP2S1
prerank,carboxylic acid binding (GO:0031406),-0.27853137575832476,-0.8525411075064195,0.6938775510204082,0.9242334519265082,1.0,16/38,24.45%,GRM7;NOS3;GRIN2B;GRIN1;MAG;GLRA1;GLRA3;GRIN3A;PSAP;PHYH;GLDC;CASTOR1;SESN1;GLUD1;NOS2;SHMT2
prerank,hyaluronic acid binding (GO:0005540),-0.3697238540315003,-0.8520542415508785,0.648910411622276,0.9193377859150571,1.0,2/10,4.51%,CEMIP;LAYN
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.369871590254803,-0.8499799224655014,0.6683168316831684,0.9177090562017035,1.0,9/11,45.47%,DDAH2;PADI2;ARG2;DDAH1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,mRNA binding (GO:0003729),0.28273094643003305,0.8490499459931711,0.7700312174817898,0.8860053011006862,1.0,64/249,20.96%,SAMD4A;DDX5;RBFOX2;EIF4G3;YBX3;RBM47;HDLBP;LUC7L2;AUH;EIF4G1;THOC2;SRSF5;SRRM2;SRSF6;SYNCRIP;SLPI;CELF1;CELF3;SCAF8;DXO;PABPC4;LARP4B;G3BP2;RBM25;ETF1;PCBP4;RBMX;SERBP1;PABPC1;RBMS3;EIF3A;ZC3H12A;SNRNP70;ANGEL2;PUM2;TDRD7;ZC3H12D;DHX9;FYTTD1;HNRNPM;DCP1A;PUM1;SF3B1;EIF2S2;AGO2;ZC3H12C;RBM14;PUM3;KHDRBS1;DHX36;ZC3H11A;SNRNP35;CIRBP;THOC5;FXR2;LSM14B;LARP4;DAZAP1;FMR1;EIF4G2;MYEF2;TRA2B;NUP98;YTHDF2
prerank,G protein-coupled receptor activity (GO:0004930),-0.20527983952613488,-0.8479267719114116,0.9354838709677419,0.9161306475088795,1.0,47/239,18.50%,ADGRL4;ADGRL3;PDGFRB;GRM3;ADGRV1;LGR4;GRM5;LPAR1;GRM1;NPR1;CALCRL;ADGRE5;RORB;P2RY14;ADGRB3;TAPT1;ADRA2A;P2RY1;GRM8;ADGRG1;ADORA2A;S1PR1;CYSLTR1;BDKRB2;PTH1R;CYSLTR2;LPAR2;S1PR3;ELOVL4;GPR37;ADGRB1;GABBR2;APLNR;HRH1;GPR176;GPR88;XPR1;GPR157;NTSR2;ADGRE1;ADGRA1;GPR37L1;ADGRB2;GPR63;VIPR2;LHCGR;LGR5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3337729787335826,-0.8468270404237566,0.6717557251908397,0.9123996145874843,1.0,8/15,26.16%,PLEKHA5;JPH2;PHLDA3;RUBCNL;LANCL2;SNX3;SH3PXD2B;PLA2G4E
prerank,dynactin binding (GO:0034452),0.41771508199420226,0.8453379795719307,0.6630630630630631,0.8898258217998881,1.0,2/12,5.11%,GSK3B;PAFAH1B1
prerank,bHLH transcription factor binding (GO:0043425),0.38436479782498634,0.8439614891667188,0.653125,0.8896577420760182,1.0,6/19,15.28%,BHLHE40;CREBBP;ISL1;KDM1A;TCF3;TWIST1
prerank,transaminase activity (GO:0008483),-0.3618768824171018,-0.8399244336899909,0.655940594059406,0.9204425075427423,1.0,6/11,33.52%,AGXT;GOT2;ABAT;BCAT1;GOT1L1;AADAT
prerank,ribosomal large subunit binding (GO:0043023),-0.3666706557197114,-0.8370404843807148,0.6692111959287532,0.9200250695972831,1.0,3/11,12.29%,CPEB2;CPSF6;NPM1
prerank,3'-5' DNA helicase activity (GO:0043138),0.39188019762672666,0.8369287746317239,0.6302250803858521,0.899110280165606,1.0,7/16,18.10%,MCM7;WRN;MCM2;DHX9;ERCC3;RECQL5;FANCM
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3715381342494226,0.8363900611805762,0.6692546583850931,0.897629629759567,1.0,5/22,15.77%,ATP2C2;ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.31056469548901866,-0.8349313932886007,0.7190332326283988,0.91843657267727,1.0,4/21,10.19%,KL;FGF1;FRS2;FGF7
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.3648807904948153,-0.8341871992396637,0.675990675990676,0.9142531605478077,1.0,2/10,6.08%,SHANK3;IGSF11
prerank,phosphate ion binding (GO:0042301),-0.3754635422401119,-0.831861346505278,0.6697038724373576,0.9129309992395934,1.0,6/10,30.08%,PDE2A;RPH3A;ADSS1;CHST14;RELA;PNP
prerank,ATPase activator activity (GO:0001671),0.37117585988674995,0.8300089646174048,0.6838006230529595,0.9061618751072403,1.0,4/20,14.62%,ATP1B1;TOR1AIP1;DNAJC1;DNAJA2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.405487169274401,0.8292567933213248,0.6521739130434783,0.9049666137852908,1.0,5/11,25.51%,ALDH3A1;RDH12;DHRS13;AKR1B10;AKR1B1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.34236263369165676,0.8284426952367278,0.6790830945558739,0.9038057271161766,1.0,16/34,30.42%,UBE2B;BIRC6;UBE2F;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2N;UBE2W;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,mannosyltransferase activity (GO:0000030),0.37027810838810793,0.8283462434542708,0.6821705426356589,0.9015271521052912,1.0,1/21,0.79%,TMTC1
prerank,glutamate receptor binding (GO:0035254),-0.3206862855893914,-0.8277851770341677,0.6963350785340314,0.9151291662857202,1.0,4/17,10.40%,SHANK3;IGSF11;CAMK2A;HIP1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.40262947162671253,0.8266533992840405,0.6804635761589404,0.9019466624249877,1.0,3/12,22.07%,SLC25A25;SLC19A1;SLC25A17
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3616731591203195,0.8264149341477589,0.6728395061728395,0.8998707330248644,1.0,3/21,8.65%,GLRB;P2RX2;P2RX4
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4125826786511989,0.8263725115074684,0.6580310880829016,0.8975189246075193,1.0,5/10,27.63%,CDKN1B;KAT2B;CDKN1A;HEXIM1;CDKN2C
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.36397914006536336,-0.8244552726575687,0.6844547563805105,0.9156214532955826,1.0,6/11,23.30%,CASP4;CFLAR;CASP3;CASP1;CASP12;PYCARD
prerank,titin binding (GO:0031432),0.39704257236351737,0.8244455376951633,0.6649916247906198,0.8985100152579939,1.0,1/13,1.74%,CAMK2D
prerank,double-stranded RNA binding (GO:0003725),0.30502288472281297,0.8194992641179369,0.7215189873417721,0.9041595634262479,1.0,13/70,18.70%,STRBP;MBNL1;SIDT2;ZFR;MTDH;DGCR8;IFIH1;DHX9;TLR8;AGO2;DROSHA;DHX36;EIF4B
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.3910196214658467,0.8165861334468786,0.6774716369529984,0.9066142881373103,1.0,3/15,20.46%,PLA2G4F;PLA2G2C;PLA2G4A
prerank,ubiquitin-specific protease binding (GO:1990381),0.37261045410129057,0.8149981332824174,0.6740157480314961,0.9067542372412317,1.0,2/19,7.52%,VCP;LCOR
prerank,GTP binding (GO:0005525),0.2731937250104188,0.8147841710285334,0.8002207505518764,0.9046849246121623,1.0,18/172,9.34%,RHOJ;ATL3;NRAS;KRAS;MRAS;RHOBTB1;BMS1;RAP1A;RAB6A;ATL2;ARL3;RHOQ;GNL1;ARF3;RRAGB;RAP2C;RHOA;RND3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.34172007301969354,0.8134412660467436,0.6988472622478387,0.904465278888475,1.0,15/31,30.42%,UBE2B;BIRC6;UBE2D3;UBE2Z;UBE2S;UBE2K;UBE2N;UBE2W;UBE2Q2;UBE2O;UBE2R2;TAF1;UBE2H;UBE2A;UBE2G1
prerank,tRNA methyltransferase activity (GO:0008175),0.38317682790148155,0.81250374218358,0.6693944353518821,0.9035885326177248,1.0,10/16,33.55%,ALKBH8;TRMT13;TARBP1;TRDMT1;THUMPD2;TRMT12;FTSJ1;METTL2B;METTL2A;TRMT44
prerank,Toll-like receptor binding (GO:0035325),-0.34630067611934123,-0.8119658408530491,0.6909975669099757,0.932582036731097,1.0,2/11,6.34%,DAB2IP;UNC93B1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.41373732521343254,0.810813406354189,0.6642984014209592,0.9037889893531647,1.0,2/10,7.26%,CACNA1C;CACNA1F
prerank,adenyl ribonucleotide binding (GO:0032559),0.2647597433367699,0.8090404600205391,0.8721174004192872,0.9042228347994008,1.0,43/291,13.69%,ME1;MAP3K5;ABCD3;MARK1;MPPED2;WNK1;SMC4;GCLC;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;MKNK2;EIF4G1;PDE10A;PFKP;IDE;P2RX2;MARK2;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;SIK2;IRAK3;ACVR1;TOP1;IGHMBP2;HACL1;MAST2;MIEF1;PPP5C;PDK3;ABCF1;PPIP5K2;ERN2;CDC42BPG;DYRK2
prerank,peptide hormone receptor binding (GO:0051428),0.4040123676612287,0.807078445893145,0.679214402618658,0.9048882408464274,1.0,2/11,17.65%,PTHLH;GNRH1
prerank,mRNA 3'-UTR binding (GO:0003730),0.29592975871708227,0.8054535208930449,0.7481751824817519,0.9051051921156349,1.0,20/79,20.05%,DDX5;YBX3;AUH;CELF1;PABPC4;LARP4B;PCBP4;SERBP1;PABPC1;RBMS3;ZC3H12A;ANGEL2;PUM2;PUM1;DHX36;CIRBP;FXR2;LARP4;DAZAP1;FMR1
prerank,ribosomal small subunit binding (GO:0043024),-0.317461156248359,-0.8038094452561908,0.7352941176470589,0.9417756173874176,1.0,7/17,25.47%,CPEB2;NPM1;PIM1;EIF4H;DDX3X;NME1;EIF1B
prerank,tumor necrosis factor receptor binding (GO:0005164),0.3947409697505271,0.8031602920967619,0.6843910806174958,0.9061445143054474,1.0,5/12,25.45%,TRAF5;TNFSF11;TRAP1;TRAF3;TRAF6
prerank,pyrophosphatase activity (GO:0016462),0.3186092000713962,0.8029608286584244,0.7309859154929578,0.9041196685778502,1.0,10/50,14.67%,ENTPD6;ALPL;NUDT4;DXO;NUDT5;ENTPD2;ENTPD7;PLPP1;DHX9;NUDT15
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3756062724986965,0.7998641770491323,0.6979332273449921,0.9066669763405042,1.0,9/17,32.75%,AK4;AK3;AK9;AK1;NME6;CLP1;AK5;CMPK1;DTYMK
prerank,retinoid X receptor binding (GO:0046965),0.3985847788707434,0.7997803182522455,0.6960950764006791,0.9044999991726542,1.0,6/11,18.78%,NR4A2;RARG;NSD1;NCOA6;PPARG;NRIP1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.25619007170275476,0.797679964845124,0.8972533062054934,0.9053846489223537,1.0,60/431,13.69%,MAP3K5;ABCD3;MARK1;RHOJ;WNK1;SMC4;ATL3;NRAS;KRAS;MRAS;PRPS2;N4BP2;BMPR1A;RHOBTB1;TLK1;ABL1;BMS1;TGFBR1;RAP1A;RAB6A;ATL2;MKNK2;EIF4G1;ARL3;RHOQ;GNL1;PFKP;IDE;ARF3;RRAGB;P2RX2;MARK2;RAP2C;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;RHOA;HSPA1L;RND3;SIK3;SIK2;IRAK3;ACVR1;TOP1;ARF4;IGHMBP2;ARHGEF5;HACL1;MAST2;PPP5C;RIT1;PDK3;ABCF1;PPIP5K2;GTPBP4;ERN2;CDC42BPG;DYRK2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.308613293123267,-0.797418707215943,0.773224043715847,0.9473946049309003,1.0,13/18,44.34%,HSD17B7;HSD11B1;HSD17B10;HSD17B1;HSD17B14;SRD5A2;HSD17B8;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3
prerank,TBP-class protein binding (GO:0017025),-0.28534880558730485,-0.7965585244326407,0.7529761904761905,0.9432848888801246,1.0,9/21,23.84%,AHR;RUVBL1;HHEX;DRAP1;RUVBL2;GTF2A1;PSMC5;DR1;THRA
prerank,glycerophospholipid flippase activity (GO:0140333),-0.3499183640832624,-0.796250105086622,0.7352941176470589,0.9384163280029328,1.0,6/11,17.26%,ABCA4;ATP8A1;ABCB4;ATP10B;ATP11C;ATP8A2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.39978881753574513,0.7961783373879735,0.7013888888888888,0.9054650188147593,1.0,4/11,26.01%,STN1;RPA1;RAD50;HNRNPA2B1
prerank,alpha-actinin binding (GO:0051393),0.34664828316508456,0.7959623492541543,0.7078125,0.9034493754328198,1.0,7/24,18.72%,CACNA1C;PDLIM7;PDLIM5;RARA;MAGI1;PDLIM4;PPARG
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.299431836343243,0.7958223208109091,0.7650063856960408,0.9013521076934331,1.0,21/69,21.76%,SOAT1;KAT6B;CREBBP;MOGAT3;PLA2G15;ELP3;ZDHHC15;HHAT;DGAT2L6;ZDHHC2;EP300;MOGAT1;ZDHHC20;KAT2B;NAA15;CERS6;CERS5;ZDHHC12;PLA2G4A;MCAT;NMT1
prerank,ATP hydrolysis activity (GO:0140603),-0.2534587084747715,-0.7954688003595612,0.8315018315018315,0.934319282133641,1.0,11/41,18.85%,ABCA4;RHOBTB3;ATP2B1;RNF213;KIF26A;RUVBL1;MYO18A;RUVBL2;ABCD2;ABCB10;DDX3X
prerank,DNA secondary structure binding (GO:0000217),0.3367381261640254,0.794465837506369,0.7252906976744186,0.9012561569480788,1.0,13/31,28.08%,ABL1;ERCC5;WRN;CLSPN;RBBP8;YY1;FANCM;NEIL3;RAD51C;XPC;RAD51AP1;RAD51B;KMT2A
prerank,protein phosphatase regulator activity (GO:0019888),-0.2389025554971671,-0.7943039699485663,0.8643410852713178,0.9308393032579608,1.0,11/53,13.75%,PPP2R2B;PPP1R16B;CALM1;PPP4R4;DMPK;PPP1R15B;PPP2R5A;LMTK2;SET;CALM3;PPP2R2C
prerank,phospholipase binding (GO:0043274),-0.33680141358024995,-0.7939656037585717,0.7670157068062827,0.9261154203320732,1.0,4/13,20.93%,ARHGAP6;BLNK;BTK;SYK
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3395789054583248,-0.7923731809377745,0.722488038277512,0.9233818303721086,1.0,4/12,18.63%,SLC38A5;SLC6A6;SLC3A2;SLC36A2
prerank,tRNA binding (GO:0000049),0.3139861229095336,0.7910846524997892,0.7431693989071039,0.9040293504270766,1.0,15/43,26.74%,TYW5;ELP5;MRPS27;IGHMBP2;ALKBH8;EIF2AK4;RPUSD4;TRMT10A;DALRD3;SEPSECS;SSB;PTCD1;NAT10;TRNAU1AP;FARS2
prerank,peptidase activator activity (GO:0016504),0.35228915481587275,0.7892064492832017,0.7136363636363636,0.9045004290293372,1.0,2/22,4.92%,TANK;VCP
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3506189111108471,0.7855253272935311,0.7365269461077845,0.9076647324996797,1.0,5/22,14.56%,DUSP16;DUSP5;DUSP10;CDKN3;SBF1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.320479725030071,0.77977126302404,0.7550143266475645,0.9137248964904108,1.0,18/33,32.48%,ERI3;EXOSC7;ANGEL1;ANGEL2;CNOT7;DIS3L2;PNLDC1;EXD2;ERI2;ERI1;PARN;EXOSC4;CNOT8;REXO2;EXOSC2;DIS3;XRN1;EXOSC3
prerank,voltage-gated anion channel activity (GO:0008308),0.3733579567426254,0.7793265226949415,0.7189542483660131,0.912008450577751,1.0,2/15,12.25%,ANO6;CLCN5
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.2192994246530921,-0.7786760604184787,0.8877005347593583,0.9398576783591869,1.0,19/73,20.04%,LGR4;NPR1;CALCRL;CYSLTR1;BDKRB2;PTH1R;CYSLTR2;SORCS2;SORCS3;GPR37;APLNR;SORCS1;GPR37L1;VIPR2;LHCGR;LGR5;EDNRB;TSHR;RXFP1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.3121580034846048,-0.7766753330039583,0.7390180878552972,0.9375758298910398,1.0,5/15,25.64%,CCR9;CCR5;CX3CR1;GPR17;CCRL2
prerank,tau protein binding (GO:0048156),0.30943615980498246,0.7764133686345133,0.7493188010899182,0.9138866426673392,1.0,9/40,14.34%,MARK1;GSK3B;CLU;MARK2;MARK3;SMAD2;PPP5C;EP300;S100B
prerank,ribonuclease activity (GO:0004540),0.2904536072067832,0.7749178751326421,0.7705345501955672,0.913768755015783,1.0,30/56,34.98%,SMG6;EXOSC7;ZC3H12A;ERN2;ZC3H12D;RNASEH2A;CNOT7;DIS3L2;AGO2;ZC3H12C;EXOSC1;RNASE6;LACTB2;RNASE3;EXOG;YBEY;CPSF3;RNASE12;EXOSC4;RNASE7;AGO3;EXOSC2;PIWIL4;EXOSC3;ZC3H12B;DICER1;NYNRIN;ELAC2;RNASEH1;PIWIL2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.33826127159552066,-0.7742583825765724,0.7586206896551724,0.9360684327292862,1.0,2/11,4.30%,KSR1;SH3RF1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3123134697663244,0.7733956804687974,0.7580419580419581,0.9137438678196169,1.0,8/38,17.95%,ANXA2;SERPINB9;SLPI;SERPING1;SERPINB7;SERPINE2;SERPINB8;SERPINA2
prerank,FMN binding (GO:0010181),0.3863445938805935,0.769756058609618,0.7152899824253075,0.9167073572270262,1.0,3/11,13.20%,IYD;PNPO;PPCDC
prerank,tubulin binding (GO:0015631),0.25262510423043205,0.7693235430277049,0.8942408376963351,0.9150482291805095,1.0,41/295,12.76%,EZR;NDRG1;UNC5C;MAPRE2;RP1;KIF13A;MTUS1;MID1;MAP7D3;FMN1;FGF13;NDEL1;CLIP1;HDGFL3;NLRP5;TBCE;KIF1B;BCAS3;PAFAH1B1;ARL3;TTLL2;SETD2;GAS2L2;KIF1C;NCALD;TOGARAM1;KIF9;CAPN6;DYNC1I1;MAP1B;MACO1;KIF7;EMD;BRCA2;KATNB1;KIF16B;MAST2;CCDC66;CHP1;TUBGCP6;RMDN3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3331166148434922,0.7678737006806136,0.7603686635944701,0.9148853183429734,1.0,5/23,11.13%,PLEKHA4;WIPI2;GBF1;COMMD1;KIF16B
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3352896442977866,-0.7667969869626905,0.7860824742268041,0.9419979511458789,1.0,1/11,4.08%,SLC22A4
prerank,snRNA binding (GO:0017069),0.30616739369893525,0.7654203544999454,0.7541436464088398,0.91611350019254,1.0,14/42,28.58%,SNRNP70;LSM11;SNRPB2;DDX21;RNPC3;LSM8;LSM2;SNRNP35;CCNT1;LSM4;SF3B3;HEXIM1;CCNT2;NCBP2
prerank,Hsp70 protein binding (GO:0030544),-0.25771080934816387,-0.7653279746881815,0.845679012345679,0.9388348791298843,1.0,11/31,28.44%,RPS3;ERN1;SACS;SNCA;GPR37;PACRG;DNAJC10;HIKESHI;FICD;CYP2E1;RNF207
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.30297892331512355,0.7638512362647686,0.7981029810298103,0.9159436972510939,1.0,12/44,20.83%,SMYD2;KMT2C;SETD2;EHMT1;EED;KMT2D;SETD5;NSD1;KMT5A;EHMT2;ASH1L;KMT5B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.2820174189784913,-0.7632201667359746,0.8184438040345822,0.9264447534205672,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.2820174189784913,-0.7632201667359746,0.8184438040345822,0.9264447534205672,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,serotonin receptor activity (GO:0099589),-0.2820174189784913,-0.7632201667359746,0.8184438040345822,0.9264447534205672,1.0,5/22,15.04%,CHRM2;HTR2C;CHRM3;HTR2A;HRH1
prerank,muscle alpha-actinin binding (GO:0051371),0.3542749354365104,0.7615073097781594,0.7251655629139073,0.9170469015228525,1.0,2/15,6.45%,PDLIM7;PDLIM5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.32667991642834115,0.7576926015094088,0.7700453857791225,0.9202614711284973,1.0,7/25,13.37%,PLEKHA4;GAB2;ZFYVE1;COMMD1;KIF16B;FCHSD2;DAPP1
prerank,regulatory RNA binding (GO:0061980),0.3099049187447563,0.7541517535383843,0.7953890489913544,0.9229267593322832,1.0,11/38,20.05%,ZC3H7A;ZC3H12A;PUM2;DHX9;TUT7;PUM1;AGO2;DDX21;TUT4;MATR3;FMR1
prerank,poly-pyrimidine tract binding (GO:0008187),0.33145761961893716,0.7534994357960275,0.7787742899850523,0.9215469190206321,1.0,10/23,21.68%,HNRNPH1;PABPC4;U2AF2;PABPC1;RBMS3;DIS3L2;KHDRBS1;DAZAP1;FMR1;SSB
prerank,peptidase inhibitor activity (GO:0030414),0.31635230982014595,0.7506471204201884,0.7808823529411765,0.9231291690797749,1.0,6/33,12.24%,GPC3;CAST;TIMP2;SLPI;TIMP1;RENBP
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.35182837355754715,0.7502761054723921,0.7768729641693811,0.9191971741782989,1.0,4/16,15.77%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.35182837355754715,0.7502761054723921,0.7768729641693811,0.9191971741782989,1.0,4/16,15.77%,ATP6V0A4;ATP6V0D1;TCIRG1;ATP6V0E1
prerank,hexosaminidase activity (GO:0015929),0.37219409599037545,0.7437090928968819,0.768313458262351,0.9259055780546942,1.0,7/12,24.53%,HEXA;SPAM1;NAGA;OGA;CEMIP2;HEXD;HYAL3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3043258392938583,0.7425316241494434,0.7843137254901961,0.9252966720017946,1.0,7/35,13.02%,PTK2B;CLK1;ABL1;FRK;SRMS;CSK;YES1
prerank,signal sequence binding (GO:0005048),-0.24052906911187033,-0.7420515505398302,0.8940397350993378,0.9503804165634246,1.0,2/35,2.89%,CEMIP;PEX5L
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.31069923261640464,0.7418640495939233,0.8014285714285714,0.9238988684393558,1.0,18/35,36.05%,FTO;TRMT13;PUS10;DUS1L;TRDMT1;MTFMT;QTRT1;ELAC1;TRMT12;FTSJ1;DUS4L;TRPT1;PTRH2;GATC;QRSL1;ELAC2;DUS2;ALKBH1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.30721918652184166,-0.7410196512658543,0.8256658595641646,0.9466638881590274,1.0,2/13,5.91%,PIP5K1B;PIK3C2A
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.36495348112208453,0.7383069127352007,0.7564322469982847,0.926200673402747,1.0,1/11,2.90%,SGMS2
prerank,ATP binding (GO:0005524),0.24135236424246848,0.7342353999795134,0.9327731092436975,0.9295282252108644,1.0,38/266,13.69%,MAP3K5;ABCD3;MARK1;WNK1;SMC4;PRPS2;N4BP2;BMPR1A;TLK1;ABL1;TGFBR1;MKNK2;EIF4G1;PFKP;IDE;P2RX2;MARK2;CARS2;NLK;P2RX4;ATP1A3;ATP1A1;HSPA1L;SIK3;SIK2;IRAK3;ACVR1;TOP1;IGHMBP2;HACL1;MAST2;PPP5C;PDK3;ABCF1;PPIP5K2;ERN2;CDC42BPG;DYRK2
prerank,myosin V binding (GO:0031489),0.3449268893023468,0.731485868891027,0.7800963081861958,0.9308941587268591,1.0,6/15,30.06%,RAB6A;RAB25;RAB27B;RAB11B;RAB8A;RAB10
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3461951413046185,0.7312983404610345,0.7644151565074135,0.9267237003951373,1.0,2/16,3.68%,ANO6;ANO9
prerank,intracellular chloride channel activity (GO:0061778),0.3461951413046185,0.7312983404610345,0.7644151565074135,0.9267237003951373,1.0,2/16,3.68%,ANO6;ANO9
prerank,adrenergic receptor binding (GO:0031690),0.33917182953226666,0.729166247252697,0.7844690966719493,0.9272425814588515,1.0,1/16,1.48%,NEDD4
prerank,chemokine receptor binding (GO:0042379),-0.23490239637980243,-0.7274714399330371,0.9049295774647887,0.9587425518800082,1.0,14/35,31.54%,CXCL12;CCL19;CX3CL1;CCL2;CX3CR1;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.35372238909775977,0.7236821912582521,0.7661016949152543,0.9319689720580808,1.0,1/13,2.08%,ARHGDIB
prerank,general transcription initiation factor binding (GO:0140296),-0.24903313033965527,-0.7236552256573686,0.8705501618122977,0.958409238805997,1.0,10/25,25.23%,AHR;RUVBL1;HHEX;DRAP1;RUVBL2;GTF2A1;PSMC5;DR1;THRA;RELA
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.29885584678495436,0.7173319663080956,0.7944606413994169,0.9379355062420315,1.0,8/30,15.90%,CAST;SERPINB9;BIRC6;BIRC7;UBE2Z;CARD16;PRDX5;DPEP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3434624666996644,0.716641739579098,0.7636054421768708,0.9366053822695416,1.0,3/12,13.00%,PIK3C2B;ATM;PIK3R3
prerank,5'-3' exonuclease activity (GO:0008409),0.33548590061965067,0.7103572892775033,0.78839590443686,0.9420666620951611,1.0,2/14,7.55%,EXO1;DXO
prerank,G protein-coupled receptor binding (GO:0001664),0.24539725896328693,0.7095765394475837,0.9148694665153235,0.9407885396633554,1.0,14/132,12.28%,WNT9A;LRP6;WNT11;FZD7;AGTR1;PDCD6IP;WNT16;BAMBI;FZD1;GNA13;PROK2;HOMER2;USP4;USP33
prerank,transcription coactivator binding (GO:0001223),0.32164428067607437,0.7037466350510396,0.8159126365054602,0.9456950293934258,1.0,3/20,8.79%,CIT;ESR1;RORA
prerank,thioesterase binding (GO:0031996),-0.3094774449408235,-0.7015021515093196,0.8449612403100775,0.9782704830921319,1.0,2/11,8.12%,ADRA2A;RAC1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24675387280637992,-0.7012587609435935,0.8994252873563219,0.973322903862629,1.0,4/24,10.54%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9
prerank,endoribonuclease activity (GO:0004521),0.28340786910818255,0.6970386744433381,0.8416289592760181,0.9514088615003494,1.0,9/32,23.22%,SMG6;ZC3H12A;ERN2;ZC3H12D;AGO2;ZC3H12C;LACTB2;EXOG;YBEY
prerank,gamma-tubulin binding (GO:0043015),0.3028053819286976,0.6940903718953837,0.8394863563402889,0.952748814564403,1.0,5/21,16.89%,NDRG1;BRCA2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,CXCR chemokine receptor binding (GO:0045236),0.34511555861559273,0.6935503702467181,0.7879310344827586,0.9511472859190888,1.0,2/11,8.54%,YARS1;CXCL2
prerank,ATPase regulator activity (GO:0060590),0.2814297290324532,0.6930451266168969,0.8839160839160839,0.9494673907228077,1.0,6/38,14.62%,ATP1B1;TOR1AIP1;KATNB1;DNAJC1;BAG3;DNAJA2
prerank,methyl-CpG binding (GO:0008327),-0.25334041508249383,-0.6909659954993732,0.8912386706948641,0.9784907458051767,1.0,5/22,17.93%,CXXC4;CXXC5;MBD2;PRMT1;WDR77
prerank,NADPH binding (GO:0070402),0.3260552176216029,0.6892945523303147,0.7933333333333333,0.9515941858866014,1.0,4/13,15.11%,DECR1;LBR;CBR3;HMGCR
prerank,microtubule motor activity (GO:0003777),0.2685730844085744,0.688879052915283,0.8721399730820996,0.9499020278124936,1.0,8/51,11.13%,KIF13A;KIF1B;KIF1C;KIF9;DYNC1I1;KIF7;DNAH8;KIF16B
prerank,alpha-tubulin binding (GO:0043014),-0.22443803408888907,-0.6878513918524045,0.9307958477508651,0.9763704622880441,1.0,9/31,21.67%,TTLL7;EML4;SNCA;TRPV4;PACRG;DLEC1;ARL4C;EFHC2;CDK5R1
prerank,endopeptidase activator activity (GO:0061133),-0.3080637625513256,-0.6838060160444668,0.8506024096385543,0.9751522516482288,1.0,3/10,16.57%,APH1B;PSME2;VSIR
prerank,poly(U) RNA binding (GO:0008266),0.30854264380043556,0.6817581918902949,0.848297213622291,0.9555273771813467,1.0,10/20,24.50%,HNRNPH1;PABPC4;PABPC1;RBMS3;DIS3L2;KHDRBS1;DAZAP1;FMR1;SSB;MCRS1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.27207240210014033,0.6785504766191726,0.8674188998589563,0.9568559710089583,1.0,21/40,34.51%,NNMT;PRMT8;PCMT1;DNMT3A;CARNMT1;GNMT;TARBP1;LRTOMT;DPH5;TPMT;HNMT;ASMT;THUMPD2;RRP8;MEPCE;PCMTD2;METTL2B;METTL2A;METTL4;PCMTD1;ARMT1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.30184501560026133,0.6778166964955171,0.8589147286821706,0.9554554762525362,1.0,5/21,17.97%,EZR;AKAP9;PRRC1;ACBD3;ARFGEF1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.24506880740846962,0.677113551646825,0.9204968944099379,0.9540543259532767,1.0,8/85,8.60%,MGLL;PNPLA3;PLA2G4F;PON3;PLA2G15;ABHD6;DAGLB;PAFAH1B2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3246153861168885,0.6751172568278657,0.8267326732673267,0.954000791434953,1.0,3/14,17.55%,MTMR12;SYNJ1;MTMR11
prerank,pentosyltransferase activity (GO:0016763),0.27515341104358104,0.6708112303662002,0.8746438746438746,0.956401617696412,1.0,12/36,23.69%,LARGE1;QPRT;UPP2;TNKS2;LARGE2;SIRT6;PARP6;PARP3;UMPS;PARP4;QTRT1;PARP2
prerank,disordered domain specific binding (GO:0097718),0.28896750656895825,0.663760603735602,0.8619631901840491,0.9615062046790075,1.0,4/23,15.93%,FN1;SMAD2;RB1;DFFB
prerank,hormone activity (GO:0005179),-0.19866598887671738,-0.6585388219028666,0.9649805447470817,0.99242790319583,1.0,8/54,17.72%,IGF1;EDN1;SST;PENK;AGT;VGF;METRNL;METRN
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2659709192349542,-0.6537357821195834,0.8883116883116883,0.9914104323123126,1.0,3/15,10.70%,P2RY14;P2RY1;P2RX7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.272461369337814,-0.6532794131357292,0.8737373737373737,0.9866536011758942,1.0,2/13,6.96%,SLC38A5;SLC7A7
prerank,methyltransferase activity (GO:0008168),0.2501792418752904,0.6458160886075789,0.9228611500701263,0.9764389278262264,1.0,23/46,35.42%,EHMT1;NNMT;PRMT8;CARNMT1;LRTOMT;NDUFAF7;EEF1AKMT1;PRMT5;FTSJ3;TRMT11;EEF1AKMT4;MRM2;NSUN4;ASMT;FTSJ1;RRP8;COQ5;PRMT3;MEPCE;METTL4;ARMT1;NSUN3;COQ3
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3233482923851899,0.6391282606478097,0.8602150537634409,0.980366862143065,1.0,2/10,9.61%,IDE;USP15
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3101397088634653,0.6364068880375604,0.8653846153846154,0.9805630160683394,1.0,7/14,32.75%,AK4;AK9;AK1;NME6;AK5;CMPK1;DTYMK
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.21924926861695793,-0.6348859870934653,0.9317507418397626,0.9954073080791149,1.0,7/26,22.80%,PPP1R1A;PPP1R14A;LMTK2;SET;BOD1;PABIR1;ENSA
prerank,retinoic acid receptor binding (GO:0042974),0.29465388908820944,0.6318680066274184,0.8796747967479674,0.9825093781240626,1.0,7/17,19.80%,NR4A2;RARG;NSD1;NCOA6;PPARG;NRIP1;SNW1
prerank,chemokine activity (GO:0008009),-0.2098243401687499,-0.6312237133952152,0.9522184300341296,0.9929512584850533,1.0,12/31,31.54%,CXCL12;CCL19;CX3CL1;CCL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;PPBP;CCL8
prerank,chemokine receptor activity (GO:0004950),-0.22048230683061085,-0.6311409343389758,0.9438202247191011,0.9879600564816791,1.0,1/24,1.80%,CCR9
prerank,MAP kinase kinase activity (GO:0004708),-0.25191294298461125,-0.6283070788242427,0.917989417989418,0.9852265012625987,1.0,2/15,8.87%,MAP2K6;PAK3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2575351772921729,0.6197544776932801,0.9097633136094675,0.9904432218762872,1.0,3/29,8.46%,CIT;SPRED2;CDKN1B
prerank,Tat protein binding (GO:0030957),0.31458777096822244,0.6177114322508565,0.872852233676976,0.9899638115558135,1.0,2/10,12.62%,MDFIC;SMARCA4
prerank,syntaxin binding (GO:0019905),0.23294725772993324,0.614736197300371,0.9557291666666666,0.989941487308636,1.0,8/61,11.08%,UNC13B;ABL1;PTPN2;VPS54;SYT8;NSF;STX8;SNAP23
prerank,heme binding (GO:0020037),0.23342396804746066,0.6123398739195126,0.9573643410852714,0.9894928409621295,1.0,5/65,6.93%,CYP1B1;PTGIS;CYP2S1;HMOX2;PTGES2
prerank,lysophospholipase activity (GO:0004622),0.27446400079993405,0.6109591919272932,0.9079159935379645,0.9883668027987326,1.0,5/20,20.46%,MGLL;LYPLA2;LYPLAL1;GDPD3;PLA2G4A
prerank,NAD+ binding (GO:0070403),-0.26069918576425777,-0.6087709038850535,0.9296482412060302,0.9926248742876299,1.0,4/12,24.20%,UXS1;SIRT5;HADH;GLUD1
prerank,acetylcholine receptor activity (GO:0015464),0.26420918041390634,0.6071037181855544,0.9095022624434389,0.988911926379783,1.0,4/22,15.53%,CHRM5;CHRNG;CHRNE;CHRNB1
prerank,channel activity (GO:0015267),0.23939222957637668,0.6003144497609421,0.9512534818941504,0.9914951637790749,1.0,4/41,10.90%,TMEM120A;AQP6;MCUB;CHRNG
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.20470030877431727,-0.5896548761774817,0.9813084112149533,0.9983478517569712,1.0,13/26,32.64%,CSGALNACT1;CHSY3;CHSY1;B3GNT3;GBGT1;B3GALT2;CHPF;B4GALNT1;B3GALT1;B3GALT4;B4GALNT4;EXTL2;B3GALT5
prerank,nucleosomal DNA binding (GO:0031492),-0.2174889645359716,-0.5871152599209609,0.9699453551912568,0.9947577526777149,1.0,2/21,8.83%,ACTB;MBD2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2608145728555898,0.582770075987402,0.9178294573643411,1.0,1.0,6/18,21.53%,SERPINB9;BIRC7;PRDX5;DPEP1;BIRC3;NOL3
prerank,glutathione transferase activity (GO:0004364),-0.20912324632949691,-0.5813679642629099,0.9801136363636364,0.9924699735281538,1.0,12/23,35.59%,HPGDS;GSTA4;MGST1;GSTK1;GSTM1;ALOX5AP;GSTA3;MGST3;GSTM2;LTC4S;GSTP1;GSTZ1
prerank,DNA polymerase binding (GO:0070182),0.26344851541278186,0.5789758844526243,0.9467084639498433,1.0,1.0,4/18,17.86%,SMG6;SMARCA4;POLG2;RAD51
prerank,RNA stem-loop binding (GO:0035613),0.28711045128602775,0.5785958943704697,0.9178743961352657,0.9990862523598064,1.0,6/12,29.41%,ZC3H12A;DHX9;FMR1;EPRS1;RC3H2;CSDE1
prerank,microtubule minus-end binding (GO:0051011),0.26678843258381235,0.5732983131954362,0.9226804123711341,0.9999698466378883,1.0,4/13,21.72%,TUBGCP6;TUBGCP5;TUBGCP4;CAMSAP3
prerank,neuropeptide hormone activity (GO:0005184),-0.2109924623115578,-0.5719335444687511,0.9671232876712329,0.9917506392432937,1.0,22/22,78.94%,PENK;NPY;PNOC;PPY;GAL;CALCB;UCN;NPPA;GHRH;QRFP;NMB;NPFF;CCK;CORT;OXT;ADCYAP1;CRH;AGRP;SPX;VIP;GRP;HCRT
prerank,semaphorin receptor activity (GO:0017154),0.2856756677906243,0.5661565271419772,0.9330065359477124,1.0,1.0,3/11,18.62%,NRP1;PLXNA2;PLXNB1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2838573721540903,0.5660464772887143,0.9242957746478874,0.9973004098648716,1.0,5/11,31.46%,BAG3;GRPEL2;SIL1;BAG2;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.2838573721540903,0.5660464772887143,0.9242957746478874,0.9973004098648716,1.0,5/11,31.46%,BAG3;GRPEL2;SIL1;BAG2;BAG5
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2263423546651151,0.5651585536339423,0.9660056657223796,0.9956179607483722,1.0,8/34,19.01%,FAM20A;IQGAP1;MLST8;CAB39;STRADA;MAP2K2;CAB39L;CCNT1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2706942684101167,0.5400287020734672,0.9402460456942003,1.0,1.0,3/10,21.18%,IDE;PML;ANKRD13D
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2485594800158306,0.5342015111131845,0.9357945425361156,1.0,1.0,3/16,17.55%,MTMR12;SYNJ1;MTMR11
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.24898239835409264,0.5312787656181919,0.9559748427672956,1.0,1.0,5/16,20.66%,SMUG1;MACROD2;DNPH1;NEIL3;TDG
prerank,neuropeptide receptor activity (GO:0008188),-0.17959406422275603,-0.5273675342088538,0.990990990990991,1.0,1.0,10/29,34.86%,SORCS2;SORCS3;GPR37;SORCS1;HCRTR2;GPR143;NMUR1;NPFFR1;NPY1R;GAL
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.21439493243172258,-0.5267034927660436,0.9770408163265306,0.9987306712145524,1.0,8/14,41.96%,POP5;POP7;RPP21;PRORP;TSEN34;RPP25;RPP40;RPP14
prerank,histone methyltransferase binding (GO:1990226),0.26091765801517186,0.5243458141747681,0.9486725663716814,1.0,1.0,2/11,12.48%,LCOR;NOP56
prerank,peptide N-acetyltransferase activity (GO:0034212),0.26394735627998,0.5235136110187804,0.9396984924623115,1.0,1.0,4/10,27.51%,NAA15;NAA50;NAA80;NAA60
prerank,CCR chemokine receptor binding (GO:0048020),0.2207992188729006,0.5218722392853359,0.9715504978662873,1.0,1.0,3/28,11.35%,DEFB130A;CCL3;CCL1
prerank,O-methyltransferase activity (GO:0008171),-0.23710194947217358,-0.5214702263749036,0.9616306954436451,0.9954430986540476,1.0,1/10,7.59%,COMT
prerank,palmitoyltransferase activity (GO:0016409),0.2225685686383177,0.5205101957628497,0.9792899408284024,1.0,1.0,8/28,20.27%,ZDHHC11;ZDHHC15;HHAT;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,ribonuclease P activity (GO:0004526),-0.22607860620546505,-0.5194618064774541,0.9673366834170855,0.991216895742541,1.0,7/11,41.96%,POP5;POP7;RPP21;PRORP;RPP25;RPP40;RPP14
prerank,neuropeptide receptor binding (GO:0071855),0.24198154253272924,0.5121158804228494,0.9647058823529412,1.0,1.0,1/14,8.51%,SHANK1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.2144656187631884,-0.5038973764921253,0.9791666666666666,0.9904174693277856,1.0,2/12,15.21%,TENT5A;PAPOLB
prerank,kinesin binding (GO:0019894),0.21036926544971726,0.49652681101832435,0.9836552748885586,1.0,1.0,8/27,25.14%,KIF1B;ARHGEF10;PLEKHM2;TOR1B;NEK6;SPAG9;MAPK8IP3;CROCC
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.2201312310021693,-0.494030352339562,0.9721577726218097,0.9876813051737624,1.0,4/10,25.44%,STAMBPL1;TNFAIP3;ATXN3;CYLD
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2386250318900362,0.48611654025793505,0.9667221297836939,1.0,1.0,6/12,30.97%,PAN3;CNOT7;PNLDC1;PARN;CNOT8;CNOT1
prerank,antiporter activity (GO:0015297),0.20958422308755165,0.4697767864921111,0.9891304347826086,1.0,1.0,20/20,79.07%,ATP1A3;SLC25A14;SLC35D2;SLC25A16;CLCN4;SLC35E3;SLC35E2B;SLC35E2A;SLC25A30;SLC35A1;SLC35D3;SLC35C2;TMEM241;SLC25A10;CLCN3;SLC35C1;SLC35D1;SLC35E4;SLC25A11;SLC35E1
prerank,U6 snRNA binding (GO:0017070),0.22662919135737158,0.46163297549143323,0.9812606473594548,1.0,1.0,3/14,23.84%,LSM8;LSM2;LSM4
prerank,RNA methyltransferase activity (GO:0008173),0.2109527099164731,0.4529051639582372,0.9871175523349437,1.0,1.0,19/19,78.93%,TRMT13;TRDMT1;FTSJ3;MRM2;TGS1;TRMT12;FTSJ1;MEPCE;METTL4;BCDIN3D;TRMT5;HENMT1;FBLL1;METTL8;FBL;LCMT2;TRMT9B;TYW3;METTL3
prerank,telomerase RNA binding (GO:0070034),0.19472155873582664,0.44265043302778295,0.9888888888888889,1.0,1.0,1/22,4.46%,SMG6
prerank,carbohydrate kinase activity (GO:0019200),0.2223145129570671,0.44067524524126395,0.9809688581314879,1.0,1.0,3/11,25.30%,GALK2;GNE;POMK
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.2063129239333372,0.4376819239561189,0.9843014128728415,1.0,1.0,6/16,33.60%,CDO1;TDO2;IDO2;ALOX5;PIR;HGD
prerank,ribonuclease P RNA binding (GO:0033204),0.2067537032387648,0.41373714337707274,0.988313856427379,1.0,1.0,10/10,79.34%,RPP38;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP21;POP7;POP5
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.19917142677798005,0.40373759612912846,0.996551724137931,1.0,1.0,11/11,80.10%,CHRNB1;CHRNA4;CHRNB2;CHRNA3;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA5;CHRNA9;CHRNA7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.18145413642448405,0.3679666672696543,1.0,1.0,1.0,3/12,22.49%,NQO1;AIFM2;CRYZL1
prerank,neuropeptide binding (GO:0042923),0.15329054438989637,0.3334740762202077,1.0,1.0,1.0,5/18,31.11%,SSTR3;OPRL1;SSTR2;SORL1;NMUR2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.14681070599195356,0.30915141460718615,1.0,0.9998715959552726,1.0,5/14,30.81%,NFU1;ETFDH;IREB2;RSAD1;NUBPL
